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(57)	 ABSTRACT
We disclose measurement systems and methods for measur-
ing analytes in target regions of samples that also include
features overlying the target regions. The systems include: (a)
a light source; (b) a detection system; (c) a set of at least first,
second, and third light ports which transmit light from the
light source to a sample and receive and direct light reflected
from the sample to the detection system, generating a first set
of data including information corresponding to both an inter-
nal target within the sample and features overlying the inter-
nal target, and a second set of data including information
corresponding to features overlying the internal target; and
(d) a processor configured to remove information character-
istic of the overlying features from the first set of data using
the first and second sets of data to produce corrected infor-
mation representing the internal target.
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SYSTEMS AND METHODS FOR
CORRECTING OPTICAL REFLECTANCE
MEASUREMENTS
CROSS-REFERENCE TO RELATED
APPLICATIONS
This application claims priority to U.S. Provisional Appli-
cation No. 60/674,379 entitled "SYSTEMS AND METH-
ODS FOR CORRECTING OPTICAL REFLECTANCE
MEASUREMENTS", filed on Apr. 25, 2005, the entire con-
tents of which are incorporated herein by reference.
STATEMENT AS TO FEDERALLY SPONSORED
RESEARCH
Funding for the work described herein was provided by the
National Space Biomedical Research Institute, Grant Num-
ber SMS00403, funded under NASA Cooperative Agreement
NCC 9-58 and the U.S. Army Congressionally Directed
Medical Research Program, Grant Number DAMD17-03-1-
0005. The Federal Government may have certain rights in the
invention.
TECHNICAL FIELD
This invention relates to spectrometer systems and meth-
ods, and more particularly to spectrometer systems for reflec-
tance measurements.
BACKGROUND
Optical spectroscopy can be used to determine the concen-
tration of chemical species in gaseous, liquid, and solid
samples. The amount of light absorbed by a particular chemi-
cal species is often linearly related to its concentration
through Beer's Law, A—EIc, where  is the absorbance of the
chemical species, a is a constant specific to the chemical, l is
the path length of light, and c is the concentration of the
chemical. When incident light with an intensity, I 0 , is incident
on the sample, and I is the intensity of light after it has passed
through a solution containing the chemical to be measured,
the absorbance is given by A=log (IO/I).
For nontransparent materials, including complex materials
such as powders, tablets, natural materials (e.g., soil, agricul-
tural products), blood, skin, and muscle, optical information
can be collected via diffuse reflectance spectroscopy. In this
setting, A=(I ... /IR), where I... is the light reflected from a
100% diffuse reflectance standard, the equivalent of the inci-
dent light, and IR is the light reflected from the sample under
study. The concentration of a chemical component in one of
these complex materials is related to A, though often not
linearly. More sophisticated mathematical techniques, such
as, for example, partial least squares regression and other
multivariate calibration methods are used to determine a rela-
tionship between concentration and absorbance. Once these
calibration models are derived, they can be used to determine
chemical composition by measuring absorbance in transmit-
tance or reflectance mode.
Diffuse reflectance spectroscopy techniques with near
infrared spectroscopy ("NIRS") have been used for the non-
invasive measurement of blood and tissue chemistry in
human and animal subjects. NIRS (e.g., using a wavelength
range of about 650-1000 mu) can be used to measure a num-
ber of important medical parameters such as tissue oxygen-
ation, tissue pH, blood hematocrit ("Hct"), and glucose, but
its widespread application in medicine has been hindered by
2
both the inter- and intra-subject analyte-irrelevant variation in
tissue overlying as well as inside the structures to be mea-
sured. For example, when diffuse reflectance NIRS is used to
measure blood hematocrit in muscle or organs, the accuracy
5 of the measurements can be affected by absorbance variations
in layers overlying the muscle or organs (e.g., due to varia-
tions in the thickness of fat and skin layers between different
patients in a patient population or between different locations
on an individual patient) and/or spectral interference from
10 structural variations in muscle and/or organs that are irrel-
evant to the measurements.
Near infrared light can penetrate through a subject's skin
and bone to provide information on chemical species present
15 in blood and underlying tissue. For example, pulse oximetry,
a ubiquitous hospital monitoring system that measures arte-
rial hemoglobin oxygen saturation, is based on two-wave-
length NIRS. Multi-wavelength NIRS, in combination with
chemometrics (i.e., statistics-based methods of analyzing
20 complex spectra), can provide a platform technology for the
noninvasive measurement of several additional analytes
present in the blood and tissue. NIRS can provide accurate
and continuous measurement of medical analytes without the
need to remove a blood or tissue sample from the patient. The
25 application of this technique involves shining near infraredlight onto the skin directly or through a fiber optic bundle and
measuring the spectrum of the light that is reflected back from
the blood containing muscle. While near-infrared absorption
by hemoglobin and deoxyhemoglobin has been used to mea-
30 sure oxygen saturation levels in various tissue beds, multi-
wavelength spectroscopy in combination with additional
mathematical techniques often is required to measure addi-
tional important blood and tissue analytes. Chemometrics is a
branch of chemistry that provides statistics-based techniques
35 to process multi-wavelength spectra such that analyte con-
centration can be calculated from the reflectance spectra
recorded from complex media such as biological tissue.
Chemometrics is used to derive a mathematical relation-
ship between relevant portions of the spectra collected from a
40 sample and the concentration or amount of the analyte of
interest in the sample. The relationship between the spectra
and the chemical concentration can be expressed as a "cali-
bration equation" that can be programmed into a patient
monitor and used to determine analyte concentrations based
45 on the measured reflectance spectra. Spectra collected from
patients can be processed through calibration equations)
stored in the patient monitor, and the analyte concentration in
those patients can be reported based on the collected spectra
and the calibration equations. Because the optical reflectance
50 technique is noninvasive, the medical measurement can be
updated as often as spectra are collected, usually on the order
of a few seconds. The feasibility of using this method has
been demonstrated on the bench, in animals, and in human
subjects for the assessment of blood hematocrit, glucose,
55 cholesterol, electrolytes, lactate, myoglobin saturation,
muscle pH, and oxygen tension ("P02")'
When calibration equations are developed using chemo-
metrics, at least two sets of data are collected. A set of NIRS
spectra is recorded approximately simultaneously with an
60 independent, reliable measurement of the analyte over the
entire physiologic and pathophysiologic range. For example,
if one wanted to develop a calibration equation to determine
blood hematocrit from measured reflectance spectra, several
spectra from subjects would be compared with blood samples
65 taken from those subjects and analyzed for hematocrit in a
clinical laboratory. A chemometc technique, such as, for
example, partial least squares ("PLS") regression can be used
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to identify and correlate portions of the spectrum to the mea-
sured hematocrit. The regression coefficients are used to gen-
erate the calibration equation.
Then, when subsequent reflectance spectra are collected
from other patients, the regression coefficients can be com-
bined with the spectra of the other patients to produce the
LAIRS-determined hematocrit value for the other patients. An
advantage of using a chemometric technique such as PLS to
derive a calibration equation, rather than simple linear regres-
sion, is that PLS is adept at establishing correlation between
spectra and analytes when the analyte spectra are complicated
by other absorbing species and scattering elements (like cells
and muscle fibers).
For the calibration equation to perform accurately on
patients over a wide range of instrumental and environmental
conditions and different patient characteristics, the data in the
calibration data set should cover as wide a range of values as
possible and should encompass the entire clinically signifi-
cant range. It is also important that the data be collected under
the type of variable patient conditions that might affect the
LAIRS spectra. Conditions that affect spectra include variation
in temperature, water content, and the presence of interfering
chemical agents used to treat the patient. This helps ensure
that the calibration equations are accurate when used on
future subjects, because the effect of the interfering agents is
modeled as part of the calibration equation.
Widespread application of LAIRS for medical measurement
has been hampered by both inter- and intra-subject variation
in tissue overlying the target tissue, such as muscle, or the
target organ. Additionally, LAIRS measurement techniques
have been limited by their inaccurate performance due to
short-term changes in skin blood flow or due to long-term
variation in skin surface and texture during wound healing.
SUMMARY
The invention is based, at least in part, on the discovery that
when a spectrometer is used to record reflectance spectra
from a sample, a short distance between the light source used
to illuminate the sample and the detector used to measure
reflected light results in recording of spectra that are sensitive
to features that are relatively close to the surface of the
sample, while a longer source-detector distance results in
spectra that are sensitive to both surface features and deeper
lying (e.g., internal) features of the sample. Correcting spec-
tra recorded with a long source-detector spacing against spec-
tra recorded with a short source-detector spacing can remove
the spectral features of the overlying features from the spectra
of the internal, deeper lying features. The spectra can be
further corrected to remove features that arise from variations
in optical scattering properties of the internal features that are
not related to measurements of an analyte of interest in the
underlying layers.
Spectra can be recorded using light of different wave-
lengths. For example, the light source can provide light in one
or more of the near-infrared, infrared, visible, ultraviolet, and
other regions of the electromagnetic spectrum.
In a first aspect, the invention features measurement sys-
tems that include: (a) a light source; (b) a detection system; (c)
a set of at least first, second, and third light ports which
transmits light from the light source to a sample and receives
and directs light reflected from the sample to the detection
system, where a distance between the first port and the third
port corresponds to a first detection distance, a distance
between the second port and the third port corresponds to a
second detection distance, and the first detection distance is
larger than the second detection distance; and (d) a processor.
4
Either (i) the first and second ports are transmitting ports and
the third port is a receiving port, or (ii) the first and second
ports are receiving ports and the third port is a transmitting
port. The detection systems generate a first set of data corre-
5 sponding to the first detection distance and including infor-
mation corresponding to both an internal target within the
sample and features overlying the internal target, and a sec-
ond set of data corresponding to the second detection distance
and including information corresponding to features overly-
io ing the internal target. The processor is configured to remove
information characteristic of the overlying features from the
first set of data using the first and second sets of data to
produce corrected information representing the internal tar-
get.
15	 Embodiments can include any of the following features.
The set of at least first, second, and third ports can be
situated on a single probe. The second detection distance can
be between about I mm and about 5 mm, for example, such as
between about 1.5 mm and about 3.5 mm. The first detection
20 distance can be greater than about 10 mm (e.g., greater than
about 15 mm, greater than about 20 mm, greater than about 30
mm, greater than about 50 mm). The system can include a
shutter system for controlling whether light from the first or
second transmitting port illuminates the sample.
25 The probe head can include a thermally conductive mate-
rial to dissipate heat from the sample. The system can further
include a thermally-conductive bridge between light trans-
mitting ports and light receiving ports.
The light source can provide light in the near-infrared
30 region of the electromagnetic spectrum. The light source can
include at least one of an incandescent light source element, a
light emitting diode, a laser diode, and a laser. For example,
the light source can include an array of light emitting diodes.
The detection system can be a spectral detection system,
35 the first and second sets of data can include first and second
sets of spectra, and the processor can remove spectral infor-
mation characteristic of the overlying features from the first
set of spectra using the first and second sets of spectra to
produce corrected spectral information representing the inter-
40 nal target. The spectral detection system can include a spec-
trometer configured to receive light and to generate sets of
spectra from the received light. Alternatively, the spectral
detection system can include a first spectrometer configured
to receive light from the first receiving port and to generate the
45 first set of spectra, and a second spectrometer configured to
receive light from the second receiving port and to generate
the second set of spectra.
The processor can be configured to remove spectral infor-
mation from the first set of spectra that is characteristic of
50 variations in optical scattering properties of the internal target
that are unrelated to an analyte of interest therein. The pro-
cessor can be configured to remove spectral information from
the corrected spectral information representing the internal
target that is characteristic of variations in optical scattering
55 properties of the internal target that are unrelated to an analyte
of interest therein. The processor can be configured to remove
spectral information characteristic of the overlying features
from the first set of spectra using the first and second sets of
spectra according to the equation
60
Rory—R Ifi.—R jw7
where R f_
 
is a spectrum from the first set of spectra, R fis a
spectrum from the second set of spectra, w is a weight, "T"
65 denotes a matrix transpose operation, and ko ,,t comprises
corrected spectral information representing the internal tar-
get. The processor can be further configured to normalize the
US 7,616,303 B2
5
first and second sets of spectra with respect to one another
prior to producing the corrected spectral information.
The processor can be configured to remove spectral infor-
mation that is characteristic of variations in optical scattering
properties of the internal target from the first set of spectra by
orthogonalizing the first set of spectra with respect to a set of
loading vectors of principal components determined from a
set of spectra from a plurality of samples. The plurality of
samples can have a property of the internal target within a
selected range. For example, the property of the internal
target can be a value of an analyte such as pH, hematocrit,
tissue oxygenation, or another property. The range can be
selected to facilitate correction and/or analysis of the spectra.
For example, a selected range for pH can be 7.37±0.001 pH
units
The processor can be configured to orthogonalize the first
set of spectra by performing a set of steps that include: (a)
performing a principal component analysis on a set of cali-
bration spectra to determine a set of loading vectors corre-
sponding to principal components of the calibration spectra;
(b) determining one or more orthogonalization factors from
the principal component analysis; (c) forming a loadings
matrix having at least one dimension equal to the number of
orthogonalization factors; and (d) orthogonalizing the first set
of spectra with respect to the loadings matrix.
In another aspect, the invention features methods for cor-
recting information corresponding to an internal target within
a sample measured by a system having a light source, a
detection system, and a set of at least first, second, and third
light ports which transmits light from the light source to the
sample and receives and directs light reflected from the
sample to the detection system, where a distance between the
first port and the third port corresponds to a first detection
distance and a distance between the second port and the third
port corresponds to a second detection distance, where the
first detection distance is larger than the second detection
distance, and where either (i) the first and second ports are
transmitting ports and the third port is a receiving port, or (ii)
the first and second ports are receiving ports and the third port
is a transmitting port. The methods include: (a) illuminating
the sample with one or more light ports of the set; (b) detect-
ing the reflected light with the detection system; (c) generat-
ing a first set of data corresponding to the first detection
distance and including information corresponding to both an
internal target within the sample and features overlying the
internal target, and a second set of data corresponding to the
second detection distance and including information corre-
sponding to features overlying the internal target; and (d)
removing information characteristic of the overlying features
from the first set of data using the first and second sets of data
to produce corrected information representing the internal
target.
Embodiments of the methods can include any of the fol-
lowing features.
The detection system can be a spectral detection system,
the first and second sets of data can include first and second
sets of spectra, and removing information characteristic of the
overlying features from the first set of data can include remov-
ing spectral information characteristic of the overlying fea-
tures from the first set of spectra using the first and second sets
of spectra to produce corrected spectral information repre-
senting the internal target. Removing spectral information
characteristic of overlying features of the sample from the
first set of spectra can include combining the first and second
sets of spectra according to the equation
R_ Rf -RJW7
6
where R f_
 
is a spectrum from the first set of spectra, R fis a
spectrum from the second set of spectra, w is a weight, "T"
denotes a matrix transpose operation, and Ro,,, includes cor-
rected spectral information representing the internal target.
5 The methods can further include normalizing the first and
second sets of spectra relative to one another prior to produc-
ing the corrected spectral information. Normalizing the sets
of spectra can include applying a polynomial fit between the
first and second sets of spectra. Coefficients used in the poly-
lo nomial fit can be derived from first and second sets of spectra
recorded from one or more reflectance standards.
The methods can include processing the first set of spectra
to remove spectral information characteristic of variations in
optical properties of the internal target that are unrelated to an
is analyte of interest therein. The methods can include process-
ing the corrected spectral information representing the inter-
nal target to remove spectral information that is characteristic
of variations in optical scattering properties of the internal
target that are unrelated to an analyte of interest therein.
20 Removing spectral information characteristic of variations in
optical properties of the internal target that are unrelated to an
analyte of interest therein can include orthogonalizing the
first set of spectra with respect to a set of loading vectors of
principal components determined from a set of calibration
25 spectra.
Orthogonalizing the first set of spectra with respect to a set
of loading vectors can include: (a) performing a principal
component analysis on a set of calibration spectra to deter-
30 mine a set of loading vectors corresponding to principal com-ponents of the set of calibration spectra; (b) determining one
or more orthogonalization factors from the principal compo-
nent analysis; (c) forming a loadings matrix having at least
one dimension equal to the number of orthogonalization fac-
35 tors; and (d) orthogonalizing the first set of spectra with
respect to the loadings matrix.
In another aspect, the invention features methods of mea-
suring an analyte in a subject by: (a) generating a set of
corrected spectra based on reflectance measurements from an
40 animal according to the methods disclosed herein; (b) devel-
oping one or more calibration equations based on a relation-
ship between a measurement of the analyte in the animal and
the set of corrected spectra from the animal; (c) generating a
set of corrected spectra based on reflectance measurements
45 from the subject according to the methods disclosed herein;
and (d) determining a value of the analyte in the subject based
on the one or more calibration equations and the set of cor-
rected spectra from the subject. The subject can be a human,
for example. The sets of corrected spectra can be generated
so based on reflectance measurements from the animal and the
subject are further processed to remove spectral information
characteristic of variations in optical properties of internal
targets comprising the analyte.
The invention also features methods of measuring an ana-
55 lyte in a subject by: (a) generating a set of corrected spectra
based on reflectance measurements from a first body site of
the subject according to the methods disclosed herein; (b)
developing one or more calibration equations based on a
relationship between a measurement of the analyte at the first
6o body site and the set of corrected spectra from the first body
site; (c) generating a set of corrected spectra based on reflec-
tance measurements from a second body site of the subject
according to the methods disclosed herein; and (d) determin-
ing a value of the analyte at the second body site based on the
65 one or more calibration equations and the set of corrected
spectra from the second body site. The subject can be a
human, the first body site can be an arm, and the second body
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site can be a leg. The sets of corrected spectra generated based
on reflectance measurements from the first and second body
sites can be further processed to remove spectral information
characteristic of variations in optical properties of internal
targets comprising the analyte.
Unless otherwise defined, all technical and scientific terms
used herein have the same meaning as commonly understood
by one of ordinary skill in the art to which this invention
belongs. Although methods and materials similar or equiva-
lent to those described herein can be used in the practice or
testing of the present invention, suitable methods and mate-
rials are described below. All publications, patent applica-
tions, patents, and other references mentioned herein are
incorporated by reference in their entirety. In case of conflict,
the present specification, including definitions, will control.
In addition, the materials, methods, and examples are illus-
trative only and not intended to be limiting.
Other features and advantages of the invention will be
apparent from the following detailed description, and from
the claims.
DESCRIPTION OF DRAWINGS
FIG. 1 is a schematic diagram of a spectrometer system
described herein.
FIG. 2 is a top schematic view of an optical bench and
selected components of the spectrometer system of FIG. 1.
FIG. 3 is a schematic diagram of an incandescent lamp.
FIG. 4A is schematic diagram of an arrangement of two
fiber optic cables for delivering light to a sample and a fiber
optic cable for delivering reflected light from the sample to a
spectrograph.
FIG. 4B is a schematic end view of an arrangement of fibers
in the fiber optic cable for delivering light to the sample and
fibers in the fiber optic cable for delivering reflected light
from the sample to a spectrograph.
FIG. 5A is a schematic side view of an embodiment of a
probe head for delivering light to a sample and for receiving
reflected light from the sample.
FIG. 5B is a schematic bottom view of an embodiment of a
probe head with integrated light sources.
FIG. 6A is a schematic top view of a light shield for holding
and shielding the probe head shown in FIG. 5.
FIG. 6B is a schematic top view of an alternative embodi-
ment of the light shield of FIG. 6A.
FIG. 7 is a schematic view of a shutter used in the spec-
trometer system of FIG. 1.
FIG. 8 is a circuit diagram of an electrical circuit for con-
trolling the shutter shown in FIG. 7.
FIGS. 9A-9E are graphs that show results of a correction to
remove spectral interference due to overlying layers from
reflectance spectra measured from a human subject.
FIGS.1 OA-1 OE are graphs that show results of a correction
to remove spectral interference due to overlying layers from
reflectance spectra measured from another human subject.
FIG. 11 is a graph showing values of maximum heme
absorbance versus measured blood hematocrit for uncor-
rected spectral data.
FIG. 12 is a graph showing values of maximum heme
absorbance versus measured blood hematocrit for spectral
data corrected for effects due to overlying skin and fat layers.
FIG. 13 is an image of an embodiment of a near-infrared
8
FIG. 15 is a graph showing a set of spectral absorbance
measurements from different human subjects after applica-
tion of a PCA loading correction algorithm.
FIG. 16 is a graph showing predicted pH versus measured
5 pH for a PLS model of pH based on uncorrected spectral
absorbance data.
FIG. 17 is a graph showing predicted pH versus measured
pH for a PLS model of pH based on spectra absorbance data
corrected using a PCA loading correction method.
io	 FIG. 18 is a graph showing an aqueous absorption spec-
trum for the dye ADS780WS.
FIG. 19 is a graph showing short distance absorption spec-
tra for a set of tissue-like phantom samples.
FIG. 20 is a graph showing long distance absorption spec-
15 tra for a set of tissue-like phantom samples.
FIG. 21 is a graph showing long distance absorption spec-
tra for a set of tissue-like phantom samples after short-dis-
tance corrections have been applied.
FIG. 22 is a graph showing uncorrected spectral absor-
2o bane measurements from a set of tissue-like phantom
samples.
FIG. 23 is a graph showing spectral absorbance measure-
ments from a set of tissue-like phantom samples after short-
distance corrections have been applied.
25 FIG. 24 is a graph showing spectral absorbance measure-
ments from a set of tissue-like phantom samples after SNV
scaling corrections have been applied.
FIG. 25 is a graph showing spectral absorbance measure-
ments from a set of tissue-like phantom samples after PCA
30 loading corrections have been applied.
FIG. 26 is a graph showing spectral absorbance measure-
ments from a set of tissue-like phantom samples after short-
distance corrections and SNV scaling corrections have been
applied.
35 FIG. 27 is a graph showing spectral absorbance measure-
ments from a set of tissue-like phantom samples after short-
distance corrections, SNV scaling corrections, and PCA load-
ing corrections have been applied.
FIG. 28 is a graph showing prediction results for a PLS
40 model of dye concentration based on uncorrected spectral
absorbance data.
FIG. 29 is a graph showing prediction results for a PLS
model of dye concentration based on spectral absorbance data
corrected using three different correction methods.
45 FIG. 30 is a graph showing spectral absorbance data
recorded from different subjects at similar pH levels, and
corrected using short-distance and SNV scaling correction
methods.
FIG. 31 is a graph showing the spectral absorbance data of
5o FIG. 30, further corrected using PCA loading correction
methods.
FIG. 32 is a graph showing spectral absorbance data
recorded from different subjects at different pH values and
corrected using short-distance and SNV scaling correction
55 methods.
FIG. 33 is a graph showing the spectral absorbance data of
FIG. 32, further corrected using PCA loading correction
methods.
Like reference symbols in the various drawings indicate
60 like elements.
DETAILED DESCRIPTION
reflectance spectrometer system.	 65 General Methodology
FIG. 14 is a graph showing a set of uncorrected spectral 	 As described herein, a new fiber optic sensor and associ-
absorbance measurements from different human subjects. 	 ated processor programmed and configured to perform cer-
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tain mathematical algorithms are used to extend the applica-
bility of LAIRS for the noninvasive measurement of blood and
tissue chemistry. The sensor is designed and used to remove
the interfering spectral influence of one or more tissues that
are not of interest, such as skin and fat, that overlay tissues of
interest and complicate measured signals from those tissues,
such as scattering from muscle tissue and/or from tissue of an
organ in a patient, thus permitting greater generalization of
chemometrics-based calibration equations. In particular, the
sensor has a detection port for detecting light scattered and
reflected from a patient and at least two illumination ports that
are located at different distances from the detection port.
Light from an illumination port that is close to the detection
port causes a reflectance spectrum that is due mainly to the
overlying fat and skin layers, while light from an illumination
port that is more distant from the detection port causes a
reflectance spectrum that is due to the combination of reflec-
tions from the overlying skin and fat layers as well as deeper
muscle and/or organ layers. Information in the two spectra
and generalized chemometrics-based calibration equations
can be used to extract chemical information about just the
tissue of interest, e.g., the underlying muscle and/or organ
layer.
The sensor can also be used to reduce and/or remove inter-
fering spectral influences that arises due to sample-to-sample
structural variations in tissues of interest. For example, the
sensor can be used to measure a particular analyte in one or
more muscle tissue layers that underlie skin and fat layers.
After removing the spectral influence of the skin and fat
layers from measured reflectance spectra, additional steps
can be performed by the sensor to remove spectral influences
that arise from variations in optical properties of the muscle
tissue. For example, optical properties of the muscle tissue
can vary according to a surface texture, and/or a capillary
density, and/or a fiber structure, and/or other structural prop-
erties of the muscle tissue. Variations in optical properties of
the tissues of interest typically affect an optical scattering
coefficient of the tissue.
By generalizing the calibration equations based on cor-
rected reflectance spectra, the sensor can be used to perform
accurate measurements when placed on muscle or other tis-
sue sites different from those used for calibration develop-
ment, and calibration equations developed from animal mod-
els of pathophysiology can be applied to human subjects with
clinically acceptable results. The methods can also be applied
during clinical measurement to continually correct for vary-
ing patient conditions that will alter spectra, such as skin
blood flow and surface changes which occur during wound
healing.
The new devices and techniques described herein are
aimed at reducing spectral interference from overlying tissue
such as skin and fat on the spectra measured from underlying
muscle and/or organs. When successfully implemented, cali-
bration equations developed using these devices and tech-
niques can be applied to spectra acquired from almost any
anatomical site, irrespective of the optical properties of the
overlying layer(s). Further, the new devices and techniques
are aimed at reducing spectral interference from structural
variations in tissues of interest that are not correlated to mea-
surements of a specific analyte within the tissues of interest.
Calibration equations developed based on spectra that are
corrected for structural variations in tissues of interest, e.g.,
variations that affect the optical properties of tissues of inter-
est, can be applied to different measurement regions on a
single measurement subject, and/or to different measurement
subjects. For example, calibration equations developed based
on measurements performed on a patient's arm, which has a
thin fat and skin layer, can be applied to spectra collected
from the patient's leg, which has a thicker fat and skin layer.
With a powerful light source and a sensitive detector, the
devices and techniques described herein allow accurate spec-
5 tra to be collected from internal organs by reducing spectral
interference from overlying skin, fat, and muscle layers, and
from structural variations in the internal organ tissues.
Another advantage of the new approaches is the ability to
continually compensate for changing patient conditions such
10 as variation in skin blood flow and surface texture. By remov-
ing spectral interference from the overlying layers from the
spectra of the underlying layers, variations in the overlying
layer spectra will cause little variation in the measured infor-
mation of the underlying layers obtained from the reflectance
15 spectra. By removing spectral interference from structural
variations in tissues of interest (e.g., the underlying layers),
variations in the structure of the tissues of interest will con-
tribute only relatively small variations to measured informa-
tion for selected analytes in the tissues of interest. These
20 spectral interference corrections permit a more accurate
determination of important blood and tissue chemistry
parameters from patients.
In-vivo calibration requires access to patients who have
variation in the analyte to be measured and offer the same or
25 similar pathophysiology as expected in future application of
the devices and techniques. Often, it is difficult to obtain
access to a sufficient number of subjects and even when they
are available, the variation may not be large enough to encom-
pass the entire pathophysiological range for the parameter
30 that is sought to be modeled and measured. Another issue is
how to incorporate the potential spectral interference from
new treatment methods. For instance, when developing meth-
ods of measuring muscle pH to help guide resuscitation of a
patient from shock, it may be necessary to update the calibra-
35 tion equation used for determining muscle pH to account for
new therapeutic agents used when the patient is in shock.
However, deliberately placing human test subjects in shock to
develop updated calibration equations is not possible. A supe-
rior method for developing robust calibration equations that
40 span large ranges of medical parameters and that can be
altered for new conditions and drugs would be to develop
calibration equations on animals and transfer them directly to
humans. By using animals it is possible, for instance, to
observe variations in analyte values caused by serious shock.
45 This can be done on multiple animals to validate the sensor
for this application before it is used on critically ill humans.
Also some analytes are difficult to vary reliably in a clinical
setting. However, the methods described herein will allow
calibration equations developed on animals to be transferred
50 successfully for use on human subjects. Once the spectral
influence of the overlying tissue layers are removed, the
muscle spectra of animals, such as swine, may be similar to
those of human subjects. Spectral differences in human and
animal muscle structure can be corrected using methods that
55 remove these variations. Calibration equations derived from
swine muscle can then be used for human subjects.
Overall System
As shown in FIG. 1, a portable, fiber-optic-based spectro-
60 scopic system 100 for measurement of reflectance spectra
from a sample 102 located remotely from the system includes
a lamp 104, a power supply for the lamp 106, an optical bench
108, a shutter system 110, a driver for the shutter system 112,
a spectrograph 114, a fiber optic cable 116, and a computer
65 118. Light from the lamp is manipulated by optics within the
optical bench 106 and can be controlled by a shutter system
110 that is driven by a shutter driver 112. Light can be passed
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selectively by the shutter system 110 into a first fiber optic
cable 116a or a second fiber optic cable 116d that guide the
light to the sample 102 to illuminate the sample.
When light is guided to the sample in the fiber optic cable
116a or 116d, light is reflected from the sample 102 and
collected by a third portion of the fiber optic cable 116c that
guides the reflected light from the sample 102 to the spec-
trograph 114. The reflected light is analyzed by the spec-
trograph 114 to gather information about the sample 102.
The spectrograph 114 can be a commercial portable spec-
trograph that can be operated by computer control. For
example, an Ocean Optics USB2000 spectrograph with a
grating optimized for performance in the wavelength range of
500-1000 nm can be used. The spectrograph detector can be
a 2048 element shallow-well linear CCD-array. The spec-
trograph can be equipped with a 200 micron wide slit to
increase resolution, a collection lens to increase light collec-
tion efficiency at the detector, and a long pass filter to block
light with a wavelength less than 475 mu from reaching the
detector. The USB2000 spectrograph interfaces with the
computer 118, e.g., through either a USB or RS232 port.
The system 100 further includes an on-board computer 118
for controlling the shutter driver 112, the spectrograph 114,
and for processing, storing, and displaying data from the
spectrograph.
As shown in FIG. 2, optical bench 108 includes several
primary optical components of the system. An illumination
lamp 104 provides light to illuminate the sample. A first
optical connector 212 couples the light to a first fiber-optic
cable 116a for carrying light to illuminate the sample 102. A
second optical connector 214 couples light to a second fiber-
optic cable 116d that carries light to illuminate the sample
102. A shutter 250 can select whether of the first fiber-optic
cable 116a or the second fiber optic cable 116d is illuminated
by the lamp light. Optical bench 108 is used to set up and
maintain proper alignment of the above-mentioned optical
components to enhance the accuracy and reproducibility of
the system 100 as a reflectance spectroscopy measurement
system. Optical bench 108 can be fabricated from aluminum
because aluminum can be easily machined to close tolerances
and has high thermal conductivity to promote heat dissipation
and minimize thermal stress and distortion on the compo-
nents of the system 100.
Lamp 104 can be a white light source (e.g., a tungsten-
halogen 9 W bulb such as a Welch-Allyn 8106-001 bulb) that
is driven by a specially designed power supply 106 to allow
for fast ramp-up and stable operation of the lamp. The lamp
104 can be a continuous wave ("cw") light source or a pulsed
light source. The lamp 104 is housed within its own machined
reflector, so that it is relatively easy to replace when neces-
sary, and its optical alignment is assured through the design of
the optical bench. The lamp rests against mechanical stops
that ensure that it is accurately located with respect to the fiber
optic cables 116a and 116d. Light from the lamp 104 can
focused down a center axis of the optical bench 108 by a rear
reflector 220 (e.g., an ellipsoidal reflector).
The general lamp configuration is illustrated in FIG. 3,
which shows an incandescent light source 300 that includes
an electrically resistive filament 302 within a transparent bulb
304. Filament 302 is generally made of tungsten. Bulb 304
can be made of glass, quartz, or other materials and can be
evacuated or can be filled with a halogen gas, an inert gas, or
a mixture of gases. Electrical current is supplied from a power
supply 306 to the filament 302 through electrically conduc-
tive lead wires 308 that are electrically connected to a base
310 of the light source. The electrical current causes the
filament to radiate as a blackbody. The power supply 306 can
12
supply direct current (DC) or alternating current (AC). To
ensure stable operation of the lamp 104 and a constant spec-
trum emitted from the bulb, the filament is driven by an
electrical circuit that supplies current to the filament such that
5 the temperature of the filament remains substantially con-
stant, such that a stable blackbody radiation spectrum is emit-
ted from the bulb.
Fiber Optic Cable System
10 Referring again to FIG. 1, light from the light source 104
can be used to excite an electromagnetic reflectance spectrum
of the sample 102. Light can be ported from light source 104
to the sample 102 in fiber optic cables 116a and/or 116d to
illuminate the sample and to excite the sample optically. Light
15 reflected from the sample 102 can be collected and delivered
from the sample in a fiber optic cable 116c to a spectrograph
114 that measures the reflectance spectrum of the sample 102.
Illumination light in cable 116a exits the cable and is incident
on sample 102 at a first distance (e.g., about 32 mm) from the
20 entrance to the cable 116c that collects reflected light from the
sample and guides the reflected light to the spectrograph 114
for analysis. Illumination light in cable 116d exits the cable
and is incident on sample 102 at a second distance (e.g., about
2.5 mm) from the entrance to the cable 116c that is less than
25 the first distance. Spectra from the sample that are collected
when the sample is illuminated by light from cable 116a and
from cable 116d can be used to extract detailed information
about the sample, as explained below.
Referring to FIG. 2, the fiber-optic illumination cable 116a
30 for illuminating the sample 102 can be positioned directly in
front of the lamp 104 with the end of the fiber-optic cable
116a being at the focal point of the light emitted from the
lamp 104. The cable 116a is inserted into position before
system use, and a mechanical click stop ensures that the cable
35 116a is properly positioned and secured in relation to the
lamp 104 and the reflector 220.
A second fiber optic cable 116d that also is used for illu-
minating the sample 102 is threaded into port 214 in the
optical bench, e.g., at an angle to an optical axis of reflector
40 220 of between about 5 degrees and about 90 degrees (e.g.,
between about 10 degrees and about 60 degrees, between
about 15 degrees and about 35 degrees) with respect to the
focused beam axis. Placing the cable 116d into port 214 at an
angle to the focused beam axis results in a reduced intensity of
45 light entering the cable 116d, compared to an on-axis position
of cable 116d. However, because cable 116d delivers light to
the sample at a closer distance to detection cable 116c than
cable 116a does, the amount of light reflected by the sample
and collected in detection cable 116c can be similar whether
50 the sample is illuminated with the higher intensity light from
cable 116a or the lower intensity light in cable 116d.
As shown in FIG. 4A, the fiber optic cable can include
different fiber bundles 116a, 116c, and 116d. The cable hold-
ing the sample bundles 116a or 116d can be contained in a
55 common protective sheath with the cable holding the return
bundle 116c outside the unit 100 housing the spectrograph
114 and the light source 104. The sample bundles 116a, 116c,
and 116d can be gathered together outside the housing of the
system 100, which contains spectrograph 114 and the lamp
60 104, about 8-12 inches downstream from the housing. The
cable containing the bundles 116a, 116c, and 116d connects
spectrograph 114 and the lamp 104 to a probe head 400 that
can be located at sample 102 to perform reflectance measure-
ments on sample 102.
65 As shown in FIG. 4B,at the sample end of the cable system,
a probe head 400 includes illumination bundles 116a and
116d, which are oriented perpendicular to a face of the hous-
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ing 400 and perpendicular to a surface of sample 102. Hous- 	 20 mm and about 50 mm, between about 30 mm and about 40
ing 400 can hold the ends of illumination fiber bundle 116a, 	 mm, between about 30 mm and about 32 mm) from illumi-
illumination fiber bundle 116d, and detection fiber bundle 	 nation light port 506, and directs diffusely reflected light from
116c. Fiber bundle 116a can contain approximately 2666, 50 	 the sample to unit 502 housing spectrograph 114, where the
µm glass fibers with a numerical aperture (NA) of about 0.66. 5 reflected light can be analyzed. Light port 508 can have a 1
The detection bundle of fibers in return cable 116c returns 	 mm diameter detection bundle of 50 µm glass fibers with a
reflected light from the sample to the spectrograph 114, and in 	 collective NA of 0.66.
one embodiment can contain 109, 50 µm glass fibers with a	 Probe head 400 can include an additional illumination light
NA of about 0.66. At the sample end of the fibers, the fibers 	 port 514 configured similarly to first illumination light port
are oriented perpendicularly to sample 102. Along the length io 506, but located closer to detection light port 508 than first
of the fiber optic cable, between light source 104 and spec- 	 illumination light port 506, at a distance (SD),. The distance
trograph 114 at one end and the sample 102 at the other end, 	 (SD), can be between about 1 mm and about 5 mm (e.g.,
the sample illumination bundle 116a that delivers light to the	 about 1.5 mm, about 2.5 mm, about 3 mm, about 4 mm). For
sample is optically shielded from the return bundle 116c with	 example, the center of the 1 mm fiber bundle of second
an opaque material, such as an opaque tape or plastic sheath 15 illumination light port 514 can be located about 2.5 mm from
or tube, so that any light that leaks out of illumination bundles 	 the center of the 1 mm diameter fiber bundle of detection light
116a and/or 116d is not coupled into the return bundle 116c.	 port 508, while the 3.5 mm diameter fiber bundle of first
To improve optical coupling between lamp 104 and sample 	 illumination light port 506 can be located about 30 mm from
fiber bundles 116a and 116d, a tapered NA converter can be	 the center of detection light port 508. A diameter of light port
placed at the end of sample cable bundles 116a and 116d to 20 514 can be smaller than a diameter of light port 506, so that,
convert the 0.42 NA of the light source to the 0.66 NA of the 	 although more light is incident on sample 102 from the light
fibers. This increases the collection efficiency into the fibers 	 port 506 than from light port 514, approximately the same
by about 15%.	 reflected intensity is collected by detection light port 508
To reduce the NA of the return fiber bundle to 0.22 as may 	 regardless of whether the sample is illuminated with light
be needed to ensure proper interfacing with spectrograph 114, 25 from illumination port 506 or 514. Having similar intensities
a 600 µm diameter fused silica rod can be placed at the end of 	 in the reflected spectra whether the sample is illuminated with
fiber bundle 116c. To prevent stray light from entering the	 light from illumination port 506 or 514 permits a good signal-
spectrograph 114, a black, light-absorbing epoxy or other 	 to-noise ratio to be obtained without having to integrate on the
material can be used to surround the silica rod. 	 detector for a longer time when light from one of the two
As shown in FIG. 5, light can be delivered from the unit 502 30 illumination ports is used.
housing the lamp 104 and the spectrograph 114 to the probe 	 The respective spacings between the two illumination light
head 400 that delivers light to sample 102 in a fiber bundle	 ports 506 and 514 and the detection light port 508 ((SD), and
116a and/or 116d, and light scattered from the sample can be	 (SD)2) are chosen in conjunction with the intensity and spec-
collected and routed back to spectrograph 114 in fiber bundle 	 trum of the light emitted from illumination light ports 506 and
116c. The bundles 116a, 116c, and 116d can be contained in 35 514 and the reflectance spectrum of sample 102 to obtain
a single cable that runs between housing unit 502 and probe 	 particular information about sample 102. For example, spec-
head 400, and the cable can be several meters long to allow 	 troscopic system 100 can be used to direct near infrared
convenient access to and data collection from a sample or a	 radiation (e.g., radiation having a wavelength of 700-1000
patient. To minimize cross talk between light illumination	 mu) through a human patient's skin to permit direct, nonin-
bundles 116a and 116d and light detection bundle 116c, 40 vasive measurement of blood chemistry or chemistry in tissue
bundles 116a and 116d delivering illumination light from	 beneath the skin without removing a blood or tissue sample
lamp 104 to sample 102 can be wrapped in black tape or other 	 from the patient. In particular, system 100 can be used to
opaque material so that any leaked light does not couple into	 measure muscle pH, muscle oxygen tension (P02), and blood
light return bundle 116c.	 hematocrit from continuous wave near infrared spectra
As shown in FIG. 5, probe head 400 can have an illumina- 45 obtained with the system. Shorter distance (SD), should be
tion light port 506 for delivering light to the sample that is 	 selected to properly induce reflection only from tissue that is
spatially separated by a distance (SD)2 from a detection light 	 not of interest, such as skin and fat overlying a tissue of
port 508 for receiving light from the sample. Fiber bundle 	 interest, such as muscle or tissue of an organ. As indicated
116a can be coupled horizontally into probe head 400, and	 below, this distance has been calculated for overlying skin
light from bundle 116a can be reflected from a 45 degree 5o and fat, where muscle is the tissue of interest.
mirror 510 within the probe head and directed vertically 	 To record spectral information from a human patient, ther-
towards sample 102 from light port 506. Similarly, light scat-	 mally conducting feet 520 of probe head 400 are placed in
tered from sample 102 can be collected by light port 508 and	 contact with a portion of the patient's body, light is directed
reflected by a mirror 510 into detector fiber bundle 116c. 	 from illumination ports 506 and/or 514 to the patient, and
Alternatively, fiber bundles 116a and 116c can enter probe 55 reflected light is collected in detection port 508. For example,
head 400 horizontally and then bend 90 degrees in a vertical 	 feet 520 of probe head 400 can be placed in contact with the
direction such that they are directly coupled to light ports 506	 skin on the surface of a patient's forearm, so that light can be
and 508, respectively.	 emitted from illumination light ports 506 and/or 514,
Illumination light port 506 can contain a 3.5 mm bundle of 	 reflected from tissue within a portion of the patient's body
50 µm glass fibers having an overall NA of 0.66 for directing 60 (e.g., the patient's hand, forearm, calf, thigh, stomach, or
light from housing unit 502 to sample 102. Sample 102 can 	 chest) and collected via detection light port 508. To record
include a top layer (e.g., a skin layer)102s, an overlying layer	 information from the patient's muscle, light from illumina-
(e.g., a fat layer) 102f, and an underlying layer (e.g., a muscle 	 tion light ports 506 and/or 514 penetrates through skin layer
layer)102m, and light can be reflected from any or all of the 	 102s and fat layer 102f, which is generally between about 3
layers to the detector fiber bundle 116c. Detection light port 65 mm and about 10 mm thick (e.g., between about 4 mm and
508 that is coupled to bundle 116c is spaced a distance of	 about 5 mm thick), to reach muscle layer 102m, and then the
between about 10 mm and about 100 mm (e.g., between about 	 light is scattered from the muscle layer and collected in detec-
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tion light port 508. In some embodiments, second illumina-
tion light port 514 and detection light port 508 can be located
together in one thermally conducting foot 520, e.g., in
embodiments involving detection of analytes in human
muscle.
Using lamp 104, e.g., an 8 Watt lamp, about 7 lumens of
light can be emitted from a 3.5 mm diameter illumination
light port 506 or 514, or about 25 lumens of light can be
emitted from a 6 mm diameter illumination light port. It has
been determined empirically that a spacing of about 30 mm
between illumination light port 506 and detection light port
508 allows light collected in detection light port 508 to
include a significant signal due to light scattered from muscle
tissue 102m underlying skin and fat layers 102s and 102f.
When light is emitted from second illumination light port 514
that is positioned closer to detection light port 508 than first
illumination light port 506, the light collected in detection
light port 508 includes a significant signal from light scattered
from the overlying skin and fat layers 102s and 102f. This
second signal can be used to remove signal components that
arise due to scattering and/or absorption from the overlying
skin/fat layers 102s and 102f in the overall signal recorded
when the patient's arm is illuminated with light from first
illumination light port 506. Light emitted from the two illu-
mination light ports 506 and 514 can originate from the same
lamp 104, and shutter 250 can be used to control emission of
light from each of first illumination light port 506 and second
illumination light port 514, as explained in more detail below.
Two signals corresponding to light scattering from shallow
skin/fat layers 102s and 102f and from deeper muscle layer
102m can also be obtained by using a single illumination light
port and two light detection ports, one of which is located
closer to the illumination light port than the other.
Probe head 400 and its feet 520 can be made of a thermally-
conductive material (e.g., aluminum or copper) to conduct
heat away from a patient's skin. If the probe head is made of
non-conductive material (e.g., plastic), heat delivered though
illumination light ports 506 and/or 514 can be sufficient to
dilate blood vessels in the skin and alter skin blood volume of
the patient. This effect of heat on skin blood flow can change
a reflectance spectrum recorded from the patient. A thermal
conductor in probe head 400 provides a thermal bridge
between feet 520 at opposite ends of probe head 400, so that
the temperature of a patient's tissue is substantially the same
in the vicinity of the two illumination ports 506 and 514 and
detection port 508.
Referring to FIG. 513, in some embodiments, the light
source can include one or more light-emitting diodes. Probe
head 400 includes a first light source 580 positioned within
probe head 400 to form an illumination port at a distance
(SD)2 from detection port 584. Probe head 400 also includes
a second light source 582 positioned within probe head 400 to
form an illumination port at a distance (SD), from detection
port 584. Light sources 580 and 582 do not include fiber optic
cables or other coupling elements, and are positioned such
that light from each of the sources illuminates a sample
directly. Light reflected by the sample is received by the
system via detection port 584.
Light sources 580 and 582 can each include an array of
light emitting diodes (LEDs). A number and spatial distribu-
tion of the LEDs can be selected to provide a particular
reflected light intensity in detection port 584 from each
source. For example, light source 580 can include a relatively
densely packed array of LEDs, and light source 582 can
include a less densely packed array of LEDs, so that the
reflected light received in detection port 584 from each of the
two sources is approximately equal in intensity.
LEDs used in light sources 580 and/or 582 can provide
light in varying regions of the electromagnetic spectrum. For
example, LEDs can provide light having wavelengths in the
visible and/or ultraviolet and/or near-infrared and or infrared
5 regions of the spectrum. LEDs can also provide light in other
regions of the spectrum, and in multiple regions of the spec-
trum at the same time. In some embodiments, multiple dif-
ferent types of LEDs having different light emission proper-
ties (e.g., wavelength, intensity, and other properties) can be
io provided in a single light source, such as light source 580
and/or light source 582.
In certain embodiments, light sources 580 and/or 582 can
include other types of sources (e.g., incandescent sources,
laser-based sources) integrated in probe head 400 or coupled
15 to probe head 400. Detectors such as spectrometers can be
incorporated into probe head 400, or can be optically coupled
to probe head 400, e.g., using a fiber optic cable.
Referring to FIGS. 6A and 613, the probe head 400 can be
located in proper position by a light shield 600. Light shield
20 600 has an opening 602 through which a foot 520 of probe
400 fits, an opening 604 though which illumination light port
506 fits, and an opening 606 through which a second foot 520
fits. The second foot can house illumination light port 514 fit
and detection light port 508. Thus, the light shield locates the
25 feet 520 and the illumination and detection light ports 506,
514, and 508 of probe head 400 in a fixed position. Light
shield 600 includes an opaque material that shields the
patient's body from stray light, such that only light from
illumination light ports 506 and/or 514 reaches the patient,
30 and such that light collected in detection light port 508 is due
only to light having a known spectrum that emerges from
illumination light port 506. Light shield 600 can extend about
3.5 cm in all directions from the detection light port 508 to
shield the detection port from stray light. With probe head 400
35 positioned in the light shield 600, the probe head can be
positioned against the patient's body, for example, by taping,
strapping, or sticking the light shield against the patient's
body. For example, probe head 400 can be held against light
shield 600 with double-sided adhesive, which allows probe
40 head 400 to contact the patient's skin without excessive pres-
sure that could alter the blood volume under the probe head.
As shown in FIG. 6A, in some embodiments, the light
shield can be made in one piece having a main part 601 that
has the various openings or apertures, and a cable manage-
45 ment part 603 connected to the main part 601 by a narrow
connecting region 605. In other embodiments, as shown in
FIG. 613, the light shield has a two-piece design in which the
cable management part 603 is separate from the main upper
part 601. This arrangement enables the two parts to be sepa-
50 rated by a distance greater than the length of connecting
region 605. In many of these embodiments, the light shield
cable management part 603 typically includes a clip 608 or
other mechanism that can secure a cable that contains the fiber
bundles 116a, 116c, and 116d that transport light between
55 spectrometer unit 502 and probe head 400. Clip 608 secures
the cable, so that the weight of the cable does not displace the
probe head from its location on a patient. The shield 600 can
be made from plastic, for example, or from another light-
weight opaque material. The light shield can also be made
60 from a thermally-conductive material, such as a thin sheet of
copper or aluminum to assist in the dissipation of excess heat,
so that the heat is not transferred to the patient's skin.
Optical Bench and Shutter System
65 The optical bench can include a shutter system 110 for
directing the light to different legs of the fiber optic cable
system. By controlling the path of the light in the cable
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system, the shutter system can be used to selectively illumi-
nate the sample with different illumination fibers 116a or
116d.
Referring again to FIG. 2, optical bench 108 provides a
mount for a stepper-motor 240 that actuates optical shutter 5
250 of the shutter system 110. Shutter 250 is positioned
between lamp 104 and two fiber optic cables 116a and 116d,
and is shaped such that it can either block or pass light to each
of the two fiber optic cables. In FIG. 2, only the top edge of the 10
shutter 250 is shown. A profile of opaque shutter 250 is shown
in FIG. 7. Shutter 250 is coupled to stepper motor 240 by a
shaft that passes through a hole 710 in the shutter. When the
shaft rotates, the shutter is rotated about an axis passing
through the center of the hole 710. A second shaft (not shown) 15
fixed to the optical bench 108 passes through a second hole
720 in shutter 250 and limits the rotational motion of shutter
250.
When shutter 250 is rotated maximally in the clockwise
direction, as shownin FIG. 7, hole 730 in the shutteris located 20
between lamp 104 and fiber optic cable 116a that leads to
sample 102, so that light propagates through hole 730 and
sample 102 is illuminated by light emerging from fiber bundle
116a. With shutter 250 in this position, light reflected from 25
sample 102 is collected by cable 116c and guided to spec-
trograph 114. In this position, end 740 of shutter 250 blocks
light from entering cable 116d.
When shutter 250 is rotated counterclockwise to a middle
position, such that the shaft passing through hole 720 is 30
positioned in the middle of hole 720, hole 730 is rotated out of
the beam path of the light emitted from lamp 104. Thus, light
does not pass through hole 730, and is blocked by opaque
shutter 250 from entering the sample cable 116a. Light is also
blocked from entering the fiber bundle 116d by end 740 of 35
shutter 250.
When shutter 250 is rotated maximally in the counter-
clockwise direction, light does not pass through hole 720 and
is blocked by the opaque shutter from entering sample cable
116a. Light passes over angled edge 750 of shutter 250 and
enters fiberbundle 116d and reaches spectrograph 114. In this
position, spectrograph 114 measures a reflectance spectrum
of sample 102 when the sample is illuminated by fiber bundle
116d.
Computer 118 controls shutter 250 to switch data acquisi-
tion in spectrograph 114 between collecting data in a first
channel (i.e., when sample 102 is illuminated with light from
fiber bundle 116a) and collecting data in a second channel
(i.e., when sample 102 is illuminated with light from fiber
bundle 116d). Computer 118 can control shutter 250 via a
shutter driver circuit. One embodiment of a suitable shutter
driver circuit is shown in FIG. 8. The operation of this circuit
is described in U.S. application Ser. No. 11/113,347 entitled
"SPECTROMETER SYSTEM FOR OPTICAL REFLEC-
TANCE MEASUREMENTS", filed Apr. 25, 2005, and now
published as U.S. Publication Number 2005/0259254, the
entire contents of which are incorporated herein by reference.
Computer 118 also controls how spectrograph 114 collects
data. For example, computer 118 can control an integration
time of the spectrograph detector, a number of spectra to be
averaged, and an amount of smoothing before spectra are
stored in the computer. It is possible for computer 118 to do
this independently for each channel of data acquisition.
Parameters can be chosen to maximize a response in each of
the reference channel and the sample channel without satu-
rating the detector.
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Other Spectrometer Systems
Suitable light sources for spectrometer system 100 include
incandescent sources, e.g., lamps, light emitting diodes
(LEDs), laser-based sources, and other sources. For example,
one or more LEDs can be combined to provide light for use in
making reflectance measurements from a sample. The light
provided by the various light sources can include wavelengths
in selected regions of the electromagnetic spectrum such as
the infrared and/or near-infrared region, the visible region,
the ultraviolet region, and/or other regions of the electromag-
netic spectrum, for example.
In some embodiments, spectrometer system 100 may be
configured to illuminate a sample directly, without coupling
illumination light from a light source through a fiber optic
cable. For example, the light source can be an incandescent
lamp positioned to directly illuminate a sample through an
illumination port such as an aperture. Light reflected from the
sample can then be received by one or more detectors and
analyzed.
In certain embodiments, more than one detector can be
used. For example, light can be used to illuminate a sample
from an illumination port, and illumination light reflected
from the sample can be received in two detection ports. Each
of the two detection ports can be coupled to a spectrometer
configured to measure a spectrum of the reflected light, so that
the detection system includes two spectrometers operating in
parallel. Spectral data can be acquired simultaneously at each
detection port, which can provide a speed advantage relative
to systems that have only a single spectrometer. The system
can operate without use of a shutter system for blocking and
unblocking illumination ports, which can reduce the cost of
the system and increase the system's mechanical reliability.
Spectral Correction Algorithms
There are three different correction algorithms that can be
implemented. Although each correction algorithm works
well individually, any two algorithms, or all three algorithms,
can be used together to correct measured spectral data.
1. Short-Distance Corrections
40 Spectral contributions that arise from tissue layers overly-
ing tissue layers of interest (e.g., underlying tissues) can be
corrected by subtracting the contributions due to the overly-
ing layers from reflectance spectra that include contributions
from both the overlying and underlying layers. Reflectance
45 spectra that include contributions from both types of layers,
and reflectance spectra that include contributions from sub-
stantially only overlying layers, can be measured separately
using spectrometer system 100. For example, as shown in
FIG. 5, the distance (SD)2 between illumination port 506 and
5o detection light port 508 is greater than the distance (SD),
between illumination port 514 and detection light port 508.
The distance (SD)2 can be selected such that reflectance spec-
tra R f_ recorded when sample 102 is illuminated with light
from illumination port 506 contain spectral information about
55 skin layer 102s, fat layer 102f, and muscle layer 102m. The
distance (SD), can be selected such that reflectance spectra,
R f recorded when sample 102 is illuminated with light from
illumination port 514, substantially contain spectral informa-
tion only about skin layer 102s and fat layer 102f. The instru-
60 ment parameters, fiber size, and spectrometer integration
time of system 100 can be chosen to obtain a high signal-to-
noise ratio in the reflectance spectra for the dynamic range of
the system for each illumination port and detection port.
Before subtracting out spectral information contained in
65 the R f spectra that is due to overlying layers from the spec-
trum R f- that includes information about both the overlying
and underlying tissue layers, the R f spectra can be normal-
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ized to the R f_ spectra, so that the spectra share a common
measurement space. To transform R f into  the measurement
space of R f_, a photometric mapping of the R f spectra  to the
Rf_ spectra is performed. First, reflectance spectra are
recorded from three or more optically homogenous reflec-
tance standards having reflectivity values ranging from 2% to
99% when light is incident on sample 102 from illumination
port 506 and from illumination port 514. Next, the reflectance
spectrum for each reference standard is estimated by dividing
each measured intensity spectrum by the spectrum recorded
for the 99% reference standard. For example, the estimated
reflectance, R, of the 50% standard is 50/99 (i.e., 50.5%).
Likewise, the estimated reflectance of the 99% standard is
99/99 (i.e., 100%). Finally, a wavelength-specific polynomial
model correlating spectra, R f, when the standard is
illuminated with light from second light port 514 with spec-
tra, R f_, recorded when the standard is illuminated with light
from first light port 506. Each wavelength-specific model is
used to adjust the scale of the reflectance estimates from R fto
Rf_. This procedure corrects for differences in light through-
put and collection efficiency when the different illumination
ports 506 and 514 are used. The polynomial model can be
implemented as follows:
R f„ (n, k)=aR f(n, k)2+bR f(n, k)+c	 (1)
where n and X are indices representing the target reflectance
values (2-99%) and the light wavelength, respectively, and a,
b, and c are wavelength-specific polynomial coefficients. The
polynomial coefficients allow a mapping of future measure-
ments of tissue spectra, Rf to spectra, Rf that are normal-
ized to the R f_ spectra. Equation 1 describes a second order
polynomial model. In general, however, polynomial models
of higher order (e.g., third order, fourth order, and even higher
order) can be implemented.
After normalization of the spectra recorded with light from
the two different illumination light ports 506 and 514, the
spectra recorded with the different illumination light loca-
tions are orthogonalized (i.e., the spectral components due to
the overlying layers are removed from the spectra that include
components that are due to both the overlying and underlying
layers. Orthogonalization involves matrix multiplication.
First, a wavelength dependent weight, w, indicative of a cor-
relation between the spectra R f and  R f- is determined from
the following equation:
w=R f„ 7R f(R f R f)-1	 (2)
where the superscript T indicates the transpose of a matrix,
and R f is  a vector that corresponds to a spectrum of reflected
light recorded when light is incident on sample 102 from
illumination port 514 and then photometrically mapped onto
the measurement space of R f_. After the weight is deter-
mined, the spectral features of the overlying layers can be
removed by using the following equation:
R o,r Rf -R JWT 	 (3)
where ko,,t is an orthogonalized spectrum that results after the
reflectance components due to skin and fat are removed, and
that substantially includes only information from the under-
lying (muscle) layer 102m. R.,,t can beused with PLS or other
multivariate calibration techniques to develop calibration
equations for determining chemical properties of the under-
lying layer 102m from the orthogonalized reflectance spec-
trum, Ro ,,t, where the calibration equations are independent of
the optical effects of overlying layers.
When the calibration equations are used in a medical moni-
toring device, patient spectra can be collected with a fiber
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optic probe of the same design as used to generate the cali-
bration equations, and the orthogonalized spectrum should be
calculated before it is used in the calibration equation.
2. Correction by Standard Normal Variate Scaling
5 Standard normal variate (SNV) scaling techniques can be
used to reduce scatter and other undesired contributions to
measured reflectance spectra. Suitable SNV implementations
are disclosed, for example, in R. J. Barnes et al., Applied
10 
Spectroscopy 43, 772 (1989), the entire contents of which are
incorporated herein by reference. SNV methods can be used,
for example, to reduce contributions to measured reflectance
spectra that arise from variations in optical properties of
tissues of interest, such as muscle tissues.
15 3. Correction by Principal Component Analysis Loading
In some embodiments, spectral reflectance measurements
are recorded from multiple locations on a subject's body,
and/or from multiple subjects. Variations in optical properties
of tissues of interest from one subject to another, for example,
20 can introduce variations into the reflectance data that are
unrelated to measurement analytes of interest. For example,
in muscle tissue reflectance spectra recorded from a set of
subjects, a measurement analyte of interest may be muscle
tissue pH. However, in addition to variations that arise due to
25 changes in muscle tissue pH, reflectance spectra recorded
from muscle tissues in different subjects can also include
spectral contributions that arise from variations in muscle
tissue texture, and/or capillary density, and/or fiber structure,
and/or other structural properties of the muscle tissues in the
3o different subjects. These variations in structural properties
typically produce variations in wavelength-dependent scat-
tering coefficients for the muscle tissues in the different sub-
jects.
A large set of subjects may be used to model optical prop-
35 erty variations in tissues of interest. However, the time and
expense associated with measuring and analyzing reflectance
spectra from a large set of test subjects may make this
approach impractical for clinical applications. Alternatively,
numerical algorithms can be used to reduce and/or remove
40 spectral contributions in reflectance spectra that arise from
optical property variations in tissues of interest, prior to using
the reflectance spectral data in PLS modeling applications to
measure analytes of interest.
Principal component analysis (PCA) loading corrections
45 can be used to reduce and/or remove contributions to reflec-
tance spectra that arise from analyte-irrelevant variations in
optical properties of tissues of interest (e.g., tissues in which
analytes of interest are measured). Optical properties that
exhibit such variations can include scattering properties,
5o absorption properties, tissue refractive indices, and other
properties. In general, variations in infrared absorption by
tissues of interest are also related to concentrations of one or
more analytes of interest. Accurate measurement of analytes
of interest may therefore include determining and correcting
55 for the analyte-irrelevant contributions to reflectance spectra.
PCA analysis can be used to obtain spectral "signatures" of
the analyte-irrelevant variations, which can then be removed
from the spectral reflectance data via orthogonalization steps.
PCA loading corrections can be applied during both calibra-
60 tion and predictive steps to further improve PLS models con-
structed from the corrected spectral reflectance data.
Variations in spectral reflectance measurements that arise
from variations in optical properties of tissues of interest can
be reduced and/or removed in a series of steps. For example,
65 in some embodiments, a first analysis step includes determin-
ing variations in spectral reflectance data that are not relevant
to a target analyte by PCA on a set of spectra collected from
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different subjects (and/or from different locations on the same
subject) in the same calibration set with substantially similar
values of the analyte. The variations can be expressed as a set
of loading vectors of principal spectral components obtained
from PCA. The first analysis step is described by Equation 4:
X,,,,,X,X,,__,-SP7+E	 (4)
22
In general, the algorithms disclosed herein can be applied
in a desired order to correct spectral reflectance data. The
suitability of one or more correction algorithms applied in a
selected order to reflectance data is typically assessed by
5 determining the accuracy of a PLS model for an analyte of
interest that is developed based on the corrected spectral
reflectance data (discussed in more detail in the Examples).
In Equation 4, Xo is a matrix with dimensions mo xn. Each of
the mo rows of Xo corresponds to a reflectance spectrum 10
recorded for a different sample used for PCA, and n is the
number of wavelength points in each reflectance spectrum.
The spectra in X o include analyte-irrelevant spectral reflec-
tance variations. Matrix X...... has dimensions mo xn and
includes mo rows, where each row is a Ixn vector whose 15
elements correspond to the column mean values of Xo, so that
subtracting X0, mean from Xo yields matrix Xo,m, with dimen-
sions mo xn, where Xo,m, is a mean-centered matrix of X 0 . S is
a PCA score matrix with dimensions m o xfo, where to is a
number of principal components used to model variations in 20
Xo . Matrix P is the PCA loadings matrix and has dimensions
nxfo . Matrix E, with dimensions. m oxn, is a matrix of spectral
residuals of X o that are not modeled by PCA.
In a second analysis step, spectra used for PLS calibration
and spectra used for PLS -based prediction are orthogonalized 25
with respect to the loading vectors of the principal compo-
nents obtained in the first step. Spectral contributions due to
variations in optical properties of the tissues of interest are
reduced and/or removed in the corrected spectra which result
from the second analysis step. The second analysis step is 30
described by Equation 5:
X rr(X XO,__ (m,,,)) — (X XO__,(_,,,))P.P.T+
Xo,
__,(,n,,,)=X—(X—XO,__,(_"))P1Pt	 (5)
In Equation 5, X.,,t is the orthogonalized (e.g., corrected) 35
spectral matrix with dimensions mxn, where m is the number
of samples, e.g., the m rows of Xo,,t correspond to corrected
reflectance spectra recorded from m different samples.
Matrix X with dimensions mxn corresponds to m original,
uncorrected spectra. Matrix Xo,mea„(m,,,) with dimensions 40
mxn includes m rows, where each row is a 1 xn vector whose
elements correspond to the column mean values of X o . P,
with dimensions nxf1 , is a truncated loadings matrix, where
the number of columns 1`1 is equal to a number of orthogonal-
ization factors used in the orthogonalization procedure. In 45
general, 1`1 is less than or equal to t o, and a value for f1 is
selected on the basis of the element values in the S and P
matrices calculated in Equation 4. Following orthogonaliza-
tion, the corrected reflectance spectra in matrix X.,,t can be
used in PLS calibration and/or modeling to predict values of 50
analytes of interest.
4. Combined Correction Methods
In certain embodiments, any two or all three of the short-
distance methods, SNV methods, and PCA loading methods 55
can be combined to correct reflectance spectra by removing
spectral features that do not arise from measurement analytes
of interest. For example, in some embodiments, short-dis-
tance correction methods can be applied first to a set of
reflectance measurements to correct for spectral features due 60
to tissue layers that overlie tissue layers of interest. SNV and
PCA loading corrections can then be applied to the short-
distance-corrected spectra in succession to correct for varia-
tions in optical properties in the tissue layers of interest, e.g.,
where the set of reflectance measurements includes reflec- 65
tance data measured at different locations on a subject's body,
and/or reflectance data from different subjects.
Implementation
The equations and algorithms described above can be eas-
ily implemented in hardware or in software, or in a combina-
tion of both. The invention can be implemented in computer
programs using standard programming techniques following
the method steps and figures disclosed herein. The programs
can be designed to execute on programmable processors or
computers, e.g., microcomputers, each including at least one
processor, at least one data storage system (including volatile
and non-volatile memory and/or storage elements), at least
one input device, such as a keyboard or push button array, and
at least one output device, such as a CRT, LCD, or printer.
Program code is applied to input data to perform the functions
described herein. The output information is applied to one or
more output devices such as a printer, or a CRT or other
monitor, or a web page on a computer monitor with access to
a website, e.g., for remote monitoring.
Each program used in the new system is preferably imple-
mented in a high level procedural or object oriented program-
ming language to communicate with a computer system.
However, the programs can be implemented in assembly or
machine language, if desired. In any case, the language can be
a compiled or interpreted language.
Each such computer program can be stored on a storage
medium or device (e.g., ROM or magnetic diskette) readable
by a general or special purpose programmable computer, for
configuring and operating the computer when the storage
medium or device is read by the computer to perform the
procedures described herein. The system can also be consid-
ered to be implemented as a computer-readable storage
medium, configured with a computer program, where the
storage medium so configured causes a processor in the com-
puter to operate in a specific and predefined manner to per-
form the functions described herein.
Although any communications network can be used to
obtain results from remote monitoring, the Internet or wire-
less systems provide useful choices to transmit data.
EXAMPLES
Spectral Effects of Short-Distance Corrections
Example 1
Experiments were performed to determine an optimum
distance (SD), between the illumination probe 514 and detec-
tion probe 508 to correct for the presence of skin and fat over
human muscle in an embodiment of system 100. A probe 400
with an adjustable short source-detector distance, (SD) 1 , of 2
mm-6 mm and a fixed long source-detector distance, (SD)21
of 32.5 mm was used to measure spectra from four different
anatomical positions (arm, calf, shoulder, and thigh) having
different fat layer thicknesses on four different subjects to
determine which (SD), distance would result in the lowest
variation in measurements of an analyte for measurements
performed on the different locations of the person. Ideally, the
spectral differences caused by the different fat thicknesses
from the different positions on a person should be corrected
after the orthogonalization, i.e., all four spectra measured
US 7,616,303 B2
23
from different body parts of a person should overlap, because
the same information should be recovered from a person's
muscles regardless of what body part is measured. Moreover,
the spectral difference caused by the skin color and different
fat thickness on different people should be decreased, i.e., a
better correlation between the spectra and the hematocrit
("Hct") values of patients should be obtained when the spec-
tra are orthogonalized to remove spectral contributions from
the overlying skin and fat layers.
Reflectance spectra were measured from the arm, calf,
shoulder and thigh of four human subjects using a fixed (SD)2
distance of 32.5 mm and five different (SD), distances of 1.83
mm, 2.5 mm, 3.0 mm, 4.0 mm, and 5.4 mm. The actual fat
thicknesses for the subjects were measured at different posi-
tions using ultrasound and are listed in Table I below. The
thigh position chosen for this study was on top of the rectus
femoris muscle (front thigh), where thicker fat was found
than the position on top of the vastus lateralis muscle (side
thigh). Each person's Hct level was measured via invasive
blood testing, and the levels are listed in Table 2 below.
TABLE I
Arm (mm) Calf (mm) Shoulder (mm) Thigh (mm)
SubjectA	 4.4	 3.5	 9.8	 9.5
Subject B	 1.8	 5.8	 9.0	 10.7
Subject C	 3.2	 1.4	 2.6	 2.0
Subject D	 6.3	 9.5	 11.6	 18.6
TABLE 2
SubjectA	 41.5%
	
Subject 	 	 44.8%
	
Subject 	 	 43.4%
Subject	 D	 40.8
FIGS. 9A-9E show the effects of short-distance corrections
for overlying tissue layers on the spectra recorded from a
SubjectA for different (SD), distances. The results in FIGS.
9A, 913, 9C, 9D, and 9E were obtained for (SD), distances of
1.83 mm, 2.5 mm, 3.0 mm, 4.0 mm, and 5.4 mm, respectively.
In each figure, spectra 810 are R f_ spectra obtained when
different parts of the subject's body were illuminated with
light from illumination port 506, spectra 820 are R f spectra
obtained when different parts of the subject's body were
illuminated with light from illumination port 514, and spectra
830 are orthogonalized spectra.
Differences among spectra recorded at different positions
on a subject's body appear generally as baseline shifts caused
by the different fat thicknesses, and are decreased by the
orthogonalization process. Corrected spectra 830 are closer
together than raw spectra 810. For probes having (SD), dis-
tances of 1.83 mm, 2.5 mm, and 3.0 mm, the orthogonalized
spectra are closer together and their shapes are unchanged
compared to the raw spectra. For probes having (SD), dis-
tances of 4.0 mm and 5.4 mm, the spectra are closer together
after correction, and certain features of the spectra are
changed. For example, the absorption peak due to hemoglo-
bin (Hb) at 760 nm is less pronounced after orthogonalization
at (SD), distances of 4.0 mm and 5.4 mm. This may imply that
certain useful information from the muscle layer (where sig-
nificant Hb absorption occurs) is diminished by the correction
process. This is contrary to the objective of correcting for the
influence of fat and skin layers, but keeping the muscle infor-
mation. This effect may be due to deeper light penetration at
large (SD), distances. As light penetrates more deeply inside
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tissue, more information about the muscle layer is captured,
and the correction between the short (SD), distance and the
long (SD)2 distance may sacrifice some muscle information.
Similarly, FIGS. 1OA-10E show correction results for
5 spectra from the four body parts of a Subject C for different
(SD), distances. While Subject A had Caucasian skin and
Subject C had Negroid skin, the results of the orthogonaliza-
tion process are similar for both subjects. Absolute absor-
bance values of Subject A's and Subject C's skin are quite
to different, as evidenced by a comparison of spectra 820 in
FIGS. 9A-9E with the spectra 820 in FIGS. 10A-10E. How-
ever, the corrected spectra for the two subjects, for which the
spectral components due to the skin are subtracted out, are
quite similar.
15 To examine correlations between corrected spectral reflec-
tance data and Hct values, mean absorbance values of the
spectra at the arm, calf, shoulder, and thigh of a subject were
calculated for each subject, and a relationship between the
subject's mean absorbance value and the corresponding sub-
20 ject Hct value was established for each (SD), distance before
and after short-distance corrections were applied to the
reflectance spectra. A predominant hemoglobin feature in
tissue absorption spectra is the deoxyhemoglobin peak at 760
mu, and the height of this peak in the spectra for each subject
25 should be linearly related to the hematocrit level of the sub-
ject.
Table 3 shows the R2 correlation values of the relationship
between the mean absorbance at 760 mu for 4 different ana-
tomical positions and the Hct values for the four different
30 (SD), distances (i.e., 1.83 mm, 2.5 mm, 3.0 mm, and 4.0mm).
From the values in Table 3, it can be seen that R2 improved
after the correction. This indicates that a strong correlation
between the spectra and the Hct values is established by
correcting the (SD)2 distance spectra, R f_, against the (SD),
35 distance spectra, R,,,
TABLE 3
(SD), Distance	 Before	 After
40	 1.83 mm	 0.577	 0.967
2.5 mm	 0.480	 0.996
3.0 mm	 0.471	 0.975
4.0 mm	 0.476	 0.925
45 From the above results, an (SD), distance of about 2.5 mm
may provide optimal results for this embodiment. In general,
the short source-detector distance can be determined through
experiments as described above, or through Monte Carlo
modeling, if the absorption and scattering coefficients of all
50 the sample layers are known.
Example 2
Another example of short-distance correction of reflec-
55 tance spectra to improve correlations between measured
spectral intensities and analytes of interest is shown in FIGS.
11 and 12. FIG. 11 shows a series of measurements of maxi-
mum heme absorption (including contributions from both
hemoglobin and myoglobin) in 17 different human subjects.
6o The spectral data from each subject was collected from the
flexor digitorum profundus. The spectral data in FIG. 11 is
uncorrected, and there is no strong correlation between maxi-
mum heme absorbance and blood hematocrit levels measured
for each of the subjects.
65 FIG. 12 shows maximum heme absorbance versus blood
hematocrit calculated from reflectance spectra after short-
distance corrections were applied to the reflectance spectra to
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correct for overlying skin and fat layers in the 17 subjects. A
stronger linear relationship is observed in the corrected data,
suggesting that predictive models such as PLS models based
on the corrected spectral data will more accurately estimate
hematocrit levels in patients and other subjects.
Spectral Effects of PCA Loading Corrections
Example 3
To evaluate the effects of PCA loading corrections on mea-
sured spectral reflectance data, a set of reflectance spectra
were collected from human subjects performing a handgrip
exercise, and multi-subject venous blood pH models were
developed and evaluated based on the reflectance measure-
ments. The handgrip exercise protocol included a 2 second
contraction of a subject's hand, followed by a 1 secondrelax-
ation, at four different effort levels: 15% maximum voluntary
contraction (MVC), 30% MVC, 45% MVC, and 60% MVC.
As exercise intensity increases, pH falls to a lower level at the
end of each exercise bout. Each bout was 5 minutes in length,
and bouts were conducted 40 minutes apart. Bloodwas drawn
from a venous catheter placed in a vein close to the measure-
ment muscle. Samples were obtained just prior to each bout
(to provide a baseline pH measurement), every minute during
the exercise bout, and at 5, 10, and 20 minutes post-exercise.
Blood samples were measured using an I-Stat CG4+ cartridge
(available from i-STAT, East Windsor, N.7.) to determine
venous pH. Spectral reflectance measurements were made
using an embodiment of spectrometer system 100 similar to
the embodiment shown in FIG. 13.
Spectral reflectance data was measured from six different
subjects. Accuracy of PLS-based pH prediction models was
estimated before and after PCA loading correction of the
spectral reflectance data using a "leave-one-subject-out"
cross validation procedure. In this procedure, pH determina-
tions for each subject are made based on a calibration equa-
tion developed from data measured for the other 5 subjects.
Accuracy is estimated by calculating a root mean square error
of prediction (RMSEP) between pH values obtained from
NIRS reflectance measurements and from venous blood
analysis.
FIG. 14 shows a set of calibration spectra from different
subjects at a single pH value (about 7.35) before PCA loading
corrections were applied. FIG. 15 shows the same set of
calibration spectra after PCA loading corrections were
applied. Following application of the correction procedure,
the spectra at the same pH are nearly coincident. This is
consistent with a reduction of subject-to-subject variations in
the measured reflectance data which are not related to the
analyte of interest, e.g., muscle pH.
Calibration equations were developed using PLS from
reflectance spectra and blood samples collected during the
handgrip exercise bouts. Blood pH values were interpolated
at time intervals corresponding to measured spectral data,
where appropriate. FIG. 16 shows results of measured pH (for
venous blood) versus predicted pH (from NIRS measure-
ments) for uncorrected reflectance spectra, with calibration
according to leave-one-subject-out cross-validation. The
diagonal line in the figure indicates a perfect match between
measured and predicted pH values. Predictions of pH based
on uncorrected spectra have an average correlation, measured
by coefficient of determination R2, of about 0.44, indicating
that a correspondence between measured and estimated pH
values is not strong.
FIG. 17 shows results of measured pH versus predicted pH
based on reflectance spectra that were corrected using PCA
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loading correction methods. The R 2 for the correspondence
between measured and predicted pH values based on the
corrected spectra is about 0.64 and the predicted pH values
are more closely clustered along the diagonal line, indicating
5 that the pH model based on the corrected spectra is signifi-
cantly more accurate than the model of FIG. 16. The RMSEP
is 0.025 pH units, which describes the observed scatter
around the diagonal line.
10 Spectral Effects of Combined Correction Algorithms
Example 4
To evaluate the effects of combining multiple spectral cor-
15 rection algorithms, three-layer (e.g., skin, fat, and muscle)
tissue-like solidphantoms were prepared. Agar (AgarA7049,
available from Sigma-Aldrich Inc., St. Louis, Mo.) was used
as a solid base material for the phantoms. Intralipid (available
from Baxter Healthcare Corp., Deerfield, Ill.) was used as a
20 scattering layer. Fabrication followed a procedure similar, for
example, to the procedure described in R. Cubeddu et al.,
Physics in Medicine and Biology 42, 1971 (1997), the entire
contents of which are incorporated herein by reference,
except that different absorbers were used. Each layer was
25 fabricated separately, and then skin and fat layers were placed
on top of the muscle layer.
Each phantom included a 1.0 mm thick skin layer with 0.15
mg/mL melanin (Melanin M8631, available from Sigma-
Aldrich Inc., St. Louis, Mo.) as an absorber. Absorbers in the
30 muscle layer were a 2.2% solution of 6x10 -4 mL/mL India
ink (available from Scientific Device Lab Inc., Des Plaines,
Ill.) and NIR dyeADS780WS (available from American Dye
Source, Inc., Quebec, Canada) of varied concentrations.
The concentration of the India ink was selected based on
35 the concentration of blood in tissue, which is approximately
2.2%. The NIR dye has an absorption maximum at a wave-
length of about 780 mu, similar to deoxygenated hemoglobin,
while India ink has relatively wavelength-independent
absorption properties. No absorber was introduced into the fat
40 layer since human fat typically has a very low absorption
coefficient. Reduced scattering coefficients (µ ') for skin and
fat were 1.5 mm- ' and 1.2 mm- ', respectively. Tissue phan-
toms were prepared so that each phantom had a muscle-
reduced scattering coefficient (µ ') of 0.5 mm i , 0.65 mm i,
45 or 0.8 mm- ', a fat thickness of 2.0 mm, 4.0 mm, or 6.0 mm,
and a muscle dye concentration of: 6.67 µg/mL, 9.08 µg/mL,
13.31-µg/mL, 15.76 µg/mL, 17.92 µg/mL, 20.22 µg/mL,
22.58 µg/mL, 24.82 µg/mL, or 26.68 µg/mL. Sets of tissue
phantoms having one of the foregoing muscle dye concentra-
50 tion were fabricated so that each member of the set had one of
the 3 different levels of fat thickness and one of the 3 different
muscle scattering coefficients, e.g., nine different phantoms
were prepared with the same muscle dye concentration. The
phantoms were fabricated in three groups of 27 phantoms
55 with low, medium or high muscle dye concentrations, over a
period of 3 days. Samples were sealed with plastic to avoid
water loss, covered with aluminum foil to avoid photo-
bleaching, and stored in a refrigerator to be measured in
random order the day after fabrication.
60 Reflectance spectra of each of the phantoms at 2.5 mm and
30 mm source-detector (SD) separations were measured
using system 100. An 8.5 W tungsten lamp (model 7106-003,
available from Welch-Allyn Corp., Skaneateles, N.Y.) was
used for illumination of the phantoms, and a spectrometer
65 (USB2000, available from Ocean Optics Inc., Dunedin, Fla.)
was used to collect spectral reflectance data. The two-dis-
tance probe of system 100 had one detector fiber bundle and
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two source fiber bundles 30 mm (long distance) and 2.5 mm
(short distance) away from the detector bundle. A diameter of
the detector fiber bundle was 1.0 mm, and diameters of the
source fiber bundles at the long distance and at the short
distance were 3.5 mm and 1.0 mm, respectively. During col-
lection of reflectance spectra, the detector bundle was con-
nected to the spectrometer, while the two source fiber bundles
were connected to the lamp via an on-axis, or off-axis orien-
tation. Computer controlled shutter system 110 was placed in
front of the lamp to switch between the two source fiber
positions so that only a single source fiber bundle was illumi-
nated by the lamp.
Reflectance spectra collected at the short distance (2.5 mm
SD) captured information from substantially only the skin
and fat layers of the phantoms. Spectra collected at the long
distance (30 mm SD) included spectral information from the
skin, fat, and muscle layers.
Phantoms were separated into calibration and test sample
sets. Samples in the calibration set were chosen with proper-
ties that were different from those in the calibration set to test
PLS model predictions on samples which may have been
poorly and/or incompletely modeled during calibration. Spe-
cifically, phantoms with a fat thickness of 2.0 mm and various
dye concentrations and muscle scattering coefficients (a total
of 27 phantoms) were used as the test samples. The remaining
samples (a total of 54 phantoms) with fat thicknesses of 4.0
mm or 6.0 mm for each of the various dye concentrations and
muscle scattering coefficients were used for calibration. None
of the calibration samples had a fat layer with a thickness of
2.0 mm, and none of the test samples had a fat layer with a
thickness of 4.0 mm or 6.0 mm.
A PLS model for dye concentration in the phantom muscle
was created using calibration sample data, and the model was
validated by predicting muscle dye concentrations from test
sample spectra. Leave-one-out cross-validation was used to
determine the number of PLS model factors. To evaluate the
various spectral correction methods, PLS regressions were
performed with and without PCA loading corrections and/or
short-distance corrections and/or SNV scaling corrections.
Data within a spectral wavelength range from 700 nm to 900
nun was used in the analysis. Prediction accuracy of the PLS
models was described by R2 (the coefficient of determination)
between the estimated and actual dye concentrations, and an
estimated measurement error, which was calculated as a root
mean squared error of prediction (RMSEP) according to:
RMSEP=[(j1N)E, iN( ii_yi)2l ii2	 (6)
where N is a number of test samples, and y, and y^ are the
estimated and actual dye concentrations. A large R2 value and
a low RMSEP indicate that the PLS model accurately predicts
dye concentration in the phantom samples.
Various spectral correction and data analysis algorithms
were implemented in programs written in version 7.0 of the
MatlabTM programming language (available from The Math-
works Inc., Natick, Mass.) and the version 3.5 of PLS_Tool-
boxTM (available from Eigenvector Research Inc., Manson,
Wash.).
In the following examples, where short-distance correc-
tions are applied to reflectivity spectra in combination with
other spectral correction methods, the short-distance correc-
tions are applied first. Where PCA loading corrections are
applied to reflectivity spectra in combination with other spec-
tral correction methods, the PCA loading corrections are
applied last. For example, where short-distance, SNV, and
PCA loading corrections are applied to spectral data, the
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short-distance corrections are applied first, followed by the
SNV corrections, and finally the PCA loading corrections are
applied.
Six calibration samples with the same dye concentration
5 (e.g., n=6) were used to obtain PCA loadings for PCA loading
correction of spectral data. The dye concentration at which
the PCA loadings were obtained will be referred to as the
"calibration" dye concentration subsequently. Loadings were
obtained from PCA on sets of six calibration samples, with
io each set of six samples having one of nine different selected
dye concentrations. Reflectance spectra for each set of six
samples were corrected using different combinations of spec-
tral correction methods to examine the effect of the methods
and their parameters on the calculated loading vectors. To
15 determine the number of loading vectors used in PCA loading
correction, leave-one-out cross-validation calibration proce-
dures were used in PLS models for dye concentration in the
phantom samples. Calibration was performed using 1, 2, 3, 4,
and 5 PCA loading vectors at each of the selected dye con-
20 centrations. The number of loading vectors and the selected
dye concentration which produced the smallest root mean
squared error of cross-validation (RMSECV) were selected
for evaluation of the spectral correction methods. Analysis of
the phantoms determined that the first four loading vectors
25 obtained from PCA on the calibration spectra with a dye
concentration of 20.22 µg/mL, provided the best prediction
results for the test samples. The three spectral correction
methods short-distance overlayer correction, SNV correc-
tion, and PCA loading correction were compared individu-
3o ally and in combination under the above conditions.
FIG. 18 shows an absorption spectrum of theADS78OWS
dye in aqueous solution. FIGS. 19 and 20 show phantom
absorbance spectra for short distance (e.g., 2.5 mm) and long
distance (e.g., 30 mm) illumination of the phantoms, respec-
35 tively. FIG. 21 shows long distance absorbance spectra cor-
rected by applying short-distance correction methods, as dis-
cussed previously. The short distance absorbance spectra in
FIG. 19 include reflected light from only the skin and fat
layers overlying the muscle layer in the phantoms. The down-
40 ward-sloping shapes of the absorbance curves are character-
istic of the absorber melanin in the skin layer. Further, base-
line shifts among the various curves are due to different fat
layer thicknesses among the various phantoms.
Long distance spectra in FIG. 20 have spectral shapes that
45 are similar to the dye solution spectrum shown in FIG. 18. The
long distance spectra include contributions from light
reflected from phantom muscle layers, where the dye is
located. Variations in absorbance, e.g., between 700 nun and
750 mu, are due to a superposition of skin absorption and fat
5o and muscle scattering effects on the dye absorption. Short-
distance corrections reduce and/or remove skin absorption
and fat scattering effects from the spectral absorbance data.
As shown in FIG. 21, the resulting corrected spectra are more
nearly coincident and resemble more closely the spectrum
55 shown in FIG. 18 than the uncorrected spectra in FIG. 20.
However, baseline variations that are attributed to variations
in optical properties of the muscle layer (e.g., variability in
muscle layer scattering) between samples. PCA loading cor-
rection algorithms can be used to reduce or remove variations
60 that arise from the non-uniformity of the optical properties of
the muscle layer among the phantoms.
FIGS. 22-27 show absorbance spectra of six calibration
samples, each with dye concentration 20.22 µg/mL, but with
different combinations of fat layer thickness (4.0 mm or 6.0
65 mm) and muscle scattering coefficient (0.5 mm - ', 0.65
mm- ', or 0.8 mm- '). FIG. 22 shows uncorrected absorbance
spectra. If spectral effects due to fat and muscle scattering and
None 0.96 4.31 21.5 7
Short-Distance Only 0.97 3.86 19.3 7
20	 SNV Scaling Only 0.97 3.16 15.8 2
PCA Loading Only 0.95 3.66 18.3 6
Short-Dist. + SNV 0.96 2.55 12.7 2
Short-Dist. + PCA 0.96 2.69 13.4 3
SNV + PCA 0.97 1.88 9.4 6
Short-Dist. + SNV + PCA 0.97 1.08 5.3 4
25
In certain embodiments, using spectral correction methods
can reduce a number of factors used in a PLS model. For
example, when PCA loading corrections were used along or
30 in combination with the other correction methods, the number
of model factors was less than the 7 factors used in a model
based on uncorrected spectral absorbance data. As an
example, when the three correction methods were used in
combination, the PLS model for dye concentration in the
35 muscle layer of samples used 4 model factors. This reduction
In the number of factors for the concentration model was
achieved because correction of the spectral data removed
variations due to skin color, fat layer thickness, and muscle
layer optical properties that would otherwise have been mod-
40 eled with PLS regression.
Model prediction results are shown in FIG. 28 with no
correction of the spectra absorbance data, and in FIG. 29 with
correction of the spectral data using a combination of short-
distance, SNV scaling, and PCA loading corrections. The
45 diagonal line in each figures represents perfect prediction.
Comparing FIGS. 28 and 29, after correcting the spectra data
using three different correction methods, prediction results
are more closely clustered along the diagonal unity line, and
the predictive value of the PLS model is greater.
50
Example 5
The spectral correction methods disclosed herein have also
been applied to human tissue spectra. For example, where
55 spectra corresponding to different subjects, each having the
same value of a particular analyte of interest are available,
PCA loading corrections can be used to improve PLS models
based on the spectra. As an example, a range of pH values can
be obtained for a subject during periods of exercise. In gen-
60 eral, muscle and blood pH decreases during exercise as lactic
acid is produced, and then pH returns rapidly to baseline
values when exercise is halted. If absorbance spectra are
recorded continuously during periods of exercise and muscle
and/or blood pH is simultaneously monitored, it is possible to
65 obtain spectral data at different times that corresponds to the
same pH value from different subjects performing a similar
exercise protocol.
US 7,616,303 B2
30
dye concentrations were highly correlated, large prediction
errors resulted: the RMSEP was 4.31 ltg/mL, corresponding
to an error of 21.54% of the total concentration range (from
26.68 ltg/mL to 6.67 ltg/mL).
5 With short-distance corrections only, SNV scaling correc-
tions only, or PCA loading corrections only, the RMSEP of
the PLS model decreased. Combinations of two different
correction methods further decreased the RMSEP of the PLS
model, and combining all three correction methods resulted
10 in a PLS model with the lowest RMSEP, 1.08 ltg/mL, a 5.3%
percentage error, and a 3-fold decrease in RMSEP relative to
a PLS model where no correction methods were used.
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skin absorption were perfectly corrected among the various
phantoms, spectra corresponding to the same dye concentra-
tion would be overlapped. In the spectra shown in FIG. 22,
some baseline shift and flattening is observed between 700
rim and 800 rim, and is attributable to these scattering and
absorption effects.
FIG. 23 shows spectra from FIG. 22 after short-distance
corrections for the overlying skin and fat layers have been
applied to the spectra. The corrected spectra are closer to one
another as a result of the applied correction, and have shapes
that more closely resemble the absorption band of FIG. 18.
However, there are still some differences among the corrected
spectra, e.g., in the spectral region near the absorption peak at
about 780 rim. These variations arise from muscle layer scat-
tering, which is not corrected by short-distance algorithms 15
and methods.
FIG. 24 shows spectra from FIG. 22 after SNV scaling
corrections have been applied. The spectra are closer together
following application of the SNV methods, but a relatively
flat shape of the spectra indicates that skin and fat absorption
and scattering are not corrected by the SNV methods alone. In
general, SNV methods can be used to reduce and/or remove
scattering differences among multiple samples when varia-
tion among sample spectra arises primarily from scattering,
rather than analyte variation.
FIG. 25 shows spectra from FIG. 22 after PCA loading
corrections have been applied to the spectra. Four loadings
obtained from PCA of calibration samples with dye concen-
trations of 20.22 ltg/mL were used to correct the absorbance
spectra shown in FIG. 22. The corrected spectra, shown in
FIG. 25, are closer together than the original uncorrected
spectra. However, the corrected spectra still show spectral
features that are attributable to melanin absorption in the skin
layer of the samples.
Combinations of the various correction methods can also
be applied to the absorbance spectra. FIG. 26 shows spectra
from FIG. 22 after short-distance corrections and then SNV
scaling corrections were applied in succession. Compared
with the short-distance-corrected spectra of FIG. 23, the spec-
tra in FIG. 26 are closer together and baseline variations are
reduced, but are still present.
FIG. 27 shows spectra from FIG. 22 after short-distance
corrections, SNV scaling corrections, and PCA loading cor-
rections were applied in succession. The spectra in FIG. 27
are highly overlapped, and their shapes resemble relatively
closely the dye spectrum shown in FIG. 18 in the short wave-
length region from 700 rim to 780 rim. Application of all three
correction methods to the spectral absorbance data signifi-
cantly reduced spectral contributions from skin and fat layer
absorption and scattering, and different muscle scattering
coefficients arising from analyte-irrelevant variations in opti-
cal properties of the muscle layer.
PLS predictive models were constructed based on calibra-
tion data and used to predict values of dye concentration in
test samples. Spectral absorbance data for the calibration and
test samples was either uncorrected, or corrected by applying
short-distance corrections only, SNV scaling corrections
only, PCA loading corrections only, a combination of short-
distance and SNV scaling corrections, a combination of
short-distance and PCA loading corrections, a combination
of SNV scaling and PCA loading corrections, or a combina-
tion of short-distance, SNV scaling, and PCA loading correc-
tions. A summary of model prediction results is shown in
Table 4. Each PLS model has large values of R 2 (equal to or
greater than 0.95), indicating that a strong correlation exists
between predicted and measured dye concentrations. Without
any spectral processing, even though predicted and measured
TABLE 4
Spectral Correction	 RMSEP Percentage Number
Methods	 R^	 (µg/mL)	 Error	 of Factors
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To evaluate the PCA loading correction method on spectral
data from human subjects, a set of spectra and blood pH
measurements were collected from the forearms of three
human subjects performing a repetitive handgrip exercise
protocol. Each subject squeezed a test device for 4 seconds,
then relaxed for 2 seconds, repeating this pattern for a total
duration of 5 minutes. Each subject performed four different
exercise protocols at different, successively increasing force
levels, with a 30 minute rest period between each protocol.
FIG. 30 shows a set of absorbance spectra collected from
the three human subjects at time points during the exercise
protocols where the blood pH of each subject was
7.37±0.001. Short-distance and SNV scaling corrections
have been applied to the set of spectral data. FIG. 31 shows
the same set of absorbance spectra shown in FIG. 30 after
PCA loading corrections have been further applied. The
absorbance spectra in FIG. 31 have been orthogonalized with
the first four loading vectors obtained from PCA of the spec-
tra in FIG. 30. After PCA loading correction of the spectral
data, spectra from different subjects were significantly more
overlapped, indicating that spectral contributions due to opti-
cal property variations in muscle tissues from one subject to
another, which were not correlated with pH, were signifi-
cantly reduced.
FIG. 32 shows all of the spectra from each of the three
human subjects during periods of exercise at all measured pH
values. Short-distance and SNV scaling corrections have
been applied to the spectral data. FIG. 33 shows the data from
FIG. 32 after PCA loading corrections have been further
applied. The data was orthogonalized with the first four load-
ing vectors obtained from PCA of the calibration spectra in
FIG. 30 that correspond to a pH of 7.37±0.001. Application of
PCA loading corrections significantly reduced variations in
the spectra due to subject-to-subject variations in muscle
tissue optical properties. Variations among the spectra shown
in FIG. 33 correspond nominally to absorbance variations
resulting from exercise-induced changes in muscle pH levels.
Other Embodiment
It is to be understood that while the invention has been
described in conjunction with the detailed description
thereof, the foregoing description is intended to illustrate and
not limit the scope of the invention, which is defined by the
scope of the appended claims. Other aspects, advantages, and
modifications are within the scope of the following claims.
What is claimed is:
1. A measurement system, comprising:
(a) a light source;
(b) a detection system;
(c) a set of at least first, second, and third light ports, which
set transmits light from the light source to a sample and
receives and directs light reflected from the sample to the
detection system, wherein a distance between the first
port and the third port comprises a first detection dis-
tance and a distance between the second port and the
third port comprises a second detection distance,
wherein the first detection distance is larger than the
second detection distance; and wherein either (i) the first
and second ports are transmitting ports and the third port
is a receiving port, or (ii) the first and second ports are
receiving ports and the third port is a transmitting port;
and
wherein the detection system generates a first set of data
corresponding to the first detection distance and com-
prising information corresponding to both an internal
target within the sample and features overlying the inter-
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nal target, and a second set of data corresponding to the
second detection distance and comprising information
corresponding to features overlying the internal target;
and
5 (d) a processor configured to remove information charac-
teristic of the overlying features from the first set of data
using the first and second sets of data to produce cor-
rected information representing the internal target.
2. The system of claim 1, wherein the set of at least first,
10 second, and third ports is situated on a single probe.
3. The system of claim 1, wherein the detection system is a
spectral detection system, the first and second sets of data
comprise first and second sets of spectra, and wherein the
processor removes spectral information characteristic of the
15 overlying features from the first set of spectra using the first
and second sets of spectra to produce corrected spectral infor-
mation representing the internal target.
4. The system of claim 1, wherein the second detection
distance is between about 1 mm and about 5 mm.
20	 5. The system of claim 1, wherein the second detection
distance is between about 1.5 mm and about 3.5 mm.
6. The system of claim 1, wherein the first detection dis-
tance is greater than about 10 mm.
7. The system of claim 1, further comprising a shutter
25 system for controlling whether light from the first or second
transmitting port illuminates the sample.
8. The system of claim 3, wherein the spectral detection
system comprises a spectrometer configured to receive light
30 and to generate sets of spectra from the received light.
9. The system of claim 3, wherein the spectral detection
system comprises a first spectrometer configured to receive
light from the first receiving port and to generate the first set
of spectra, and a second spectrometer configured to receive
35 light from the second receiving port and to generate the sec-
ond set of spectra.
10. The system of claim 2, wherein the probe head com-
prises a thermally conductive material to dissipate heat from
the sample.
40 11. The system of claim 1, further comprising a thermally-
conductive bridge between light transmitting ports and light
receiving ports.
12. The system of claim 3, wherein the processor is further
configured to remove spectral information from the first set of
45 spectra that is characteristic of variations in optical scattering
properties of the internal target that are unrelated to an analyte
of interest therein.
13. The system of claim 3, wherein the processor is further
configured to remove spectral information from the corrected
50 spectral information representing the internal target that is
characteristic of variations in optical scattering properties of
the internal target that are unrelated to an analyte of interest
therein.
14. The system of claim 1, wherein the light source pro-
55 vides light in the near-infrared region of the electromagnetic
spectrum.
15. The system of claim 1, wherein the light source com-
prises at least one of an incandescent light source element, a
light emitting diode, a laser diode, and a laser.
60	 16. The system of claim 1, wherein the light source com-
prises an array of light emitting diodes.
17. The system of claim 3, wherein the processor is con-
figured to remove spectral information characteristic of the
overlying features from the first set of spectra using the first
65 and second sets of spectra according to the equation
R orr—R 
—R JW7
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where R f_ is a spectrum from the first set of spectra, R fis
a spectrum from the second set of spectra, w is a weight,
"T" denotes a matrix transpose operation, and Ro ,,t com-
prises corrected spectral information representing the
internal target.
18. The system of claim 3, wherein the processor is con-
figured to normalize the first and second sets of spectra with
respect to one another prior to producing the corrected spec-
tral information.
19. The system of claim 12, wherein the processor is con-
figured to remove spectral information that is characteristic of
variations in optical scattering properties of the internal target
from the first set of spectra by orthogonalizing the first set of
spectra with respect to a set of loading vectors of principal
components determined from a set of spectra from a plurality
of samples.
20. The system of claim 19, wherein the plurality of
samples have a property of the internal target within a selected
range.
21. The system of claim 19, wherein the processor is con-
figured to orthogonalize the first set of spectra by performing
a set of steps that comprise:
performing a principal component analysis on a set of
calibration spectra to determine a set of loading vectors
corresponding to principal components of the calibra-
tion spectra;
determining one or more orthogonalization factors from
the principal component analysis;
forming a loadings matrix having at least one dimension
equal to the number of orthogonalization factors; and
orthogonalizing the first set of spectra with respect to the
loadings matrix.
22. A method for correcting information corresponding to
an internal target within a sample measured by a system
having a light source, a detection system, and a set of at least
first, second, and third light ports, which set transmits light
from the light source to the sample and receives and directs
light reflected from the sample to the detection system,
wherein a distance between the first port and the third port
comprises a first detection distance and a distance between
the second port and the third port comprises a second detec-
tion distance, wherein the first detection distance is larger
than the second detection distance; and wherein either (i) the
first and second ports are transmitting ports and the third port
is a receiving port, or (ii) the first and second ports are receiv-
ing ports and the third port is a transmitting port, the method
comprising:
illuminating the sample with one or more light ports of the
set;
detecting the reflected light with the detection system;
generating a first set of data corresponding to the first
detection distance and comprising information corre-
sponding to both an internal target within the sample and
features overlying the internal target, and a second set of
data corresponding to the second detection distance and
comprising information corresponding to features over-
lying the internal target; and
removing information characteristic of the overlying fea-
tures from the first set of data using the first and second
sets of data to produce corrected information represent-
ing the internal target.
23. The method of claim 22, wherein the detection system
is a spectral detection system, the first and second sets of data
comprise first and second sets of spectra, and wherein remov-
ing information characteristic of the overlying features from
the first set of data comprises removing spectral information
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characteristic of the overlying features from the first set of
spectra using the first and second sets of spectra to produce
corrected spectral information representing the internal tar-
get.
5 24. The method of claim 23, wherein removing spectral
information characteristic of overlying features of the sample
from the first set of spectra comprises combining the first and
second sets of spectra according to the equation
10	
R_r R fi-_RS fv7
where R f_
 
is a spectrum from the first set of spectra, R fis
a spectrum from the second set of spectra, w is a weight,
"T" denotes a matrix transpose operation, and Ro ,,t com-
prises corrected spectral information representing the
15	 internal target.
25. The method of claim 23, further comprising normaliz-
ing the first and second sets of spectra relative to one another
prior to producing the corrected spectral information.
26. The method of claim 25, wherein normalizing com-
20 prises applying a polynomial fit between the first and second
sets of spectra.
27. The method of claim 26, wherein coefficients used in
the polynomial fit are derived from first and second sets of
spectra recorded from one or more reflectance standards.
25 28. The method of claim 23, further comprising processing
the first set of spectra to remove spectral information charac-
teristic of variations in optical properties of the internal target
that are unrelated to an analyte of interest therein.
29. The method of claim 23, further comprising processing
so the corrected spectral information representing the internal
target to remove spectral information that is characteristic of
variations in optical scattering properties of the internal target
that are unrelated to an analyte of interest therein.
30. The method of claim 28, wherein removing spectral
s5 information characteristic of variations in optical properties
of the internal target that are unrelated to an analyte of interest
therein comprises orthogonalizing the first set of spectra with
respect to a set of loading vectors of principal components
40 
determined from a set of calibration spectra.
31. The method of claim 30, wherein orthogonalizing the
first set of spectra with respect to a set of loading vectors
comprises:
performing a principal component analysis on a set of
45 calibration spectra to determine a set of loading vectors
corresponding to principal components of the set of
calibration spectra;
determining one or more orthogonalization factors from
the principal component analysis;
50	 forming a loadings matrix having at least one dimension
equal to the number of orthogonalization factors; and
orthogonalizing the first set of spectra with respect to the
loadings matrix.
32. A method of measuring an analyte in a subject, the
55 method comprising:
generating a set of corrected spectra based on reflectance
measurements from an animal according to the method
of claim 22;
developing one or more calibration equations based on a
60	 relationship between a measurement of the analyte in the
animal and the set of corrected spectra from the animal;
generating a set of corrected spectra based on reflectance
measurements from the subject according to the method
of claim 22; and
65 determining a value of the analyte in the subject based on
the one or more calibration equations and the set of
corrected spectra from the subject.
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33. The method of claim 32, wherein the subject is a
human.
34. The method of claim 32, wherein the sets of corrected
spectra generated based on reflectance measurements from
the animal and the subject are further processed to remove
spectral information characteristic of variations in optical
properties of internal targets is comprising the analyte.
35. A method of measuring an analyte in a subject, the
method comprising:
generating a set of corrected spectra based on reflectance
measurements from a first body site of the subject
according to the method of claim 22;
developing one or more calibration equations based on a
relationship between a measurement of the analyte at the
first body site and the set of corrected spectra from the
first body site;
36
generating a set of corrected spectra based on reflectance
measurements from a second body site of the subject
according to the method of claim 22; and
determining a value of the analyte at the second body site
5	 based on the one or more calibration equations and the
set of corrected spectra from the second body site.
36. The method of claim 35, wherein the subject is a
human, the first body site is an arm, and the second body site
is a leg.
10 37. The method of claim 35, wherein the sets of corrected
spectra generated based on reflectance measurements from
the first and second body sites are further processed to remove
spectral information characteristic of variations in optical
properties of internal targets comprising the analyte.
15
